PSS30 Assessment of Utility Loss From Diabetic Macular Edema Based on Restore Trial (Englisch)
- Neue Suche nach: Knudsen, M. S.
- Neue Suche nach: Thomas, S.
- Neue Suche nach: Gallagher, M.
- Neue Suche nach: Mitchell, P.
- Neue Suche nach: Knudsen, M. S.
- Neue Suche nach: Thomas, S.
- Neue Suche nach: Gallagher, M.
- Neue Suche nach: Mitchell, P.
In:
VALUE IN HEALTH
;
14
, 7
;
A507
;
2011
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:PSS30 Assessment of Utility Loss From Diabetic Macular Edema Based on Restore Trial
-
Beteiligte:Knudsen, M. S. ( Autor:in ) / Thomas, S. ( Autor:in ) / Gallagher, M. ( Autor:in ) / Mitchell, P. ( Autor:in )
-
Erschienen in:VALUE IN HEALTH ; 14, 7 ; A507
-
Verlag:
- Neue Suche nach: Blackwell Publishing Ltd
-
Erscheinungsdatum:01.01.2011
-
Format / Umfang:A507
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 14, Ausgabe 7
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A234
-
DA1 Artificial Neural Network Meta-Models in Cost-Effectiveness analysis of intensive Blood-Glucose Control: A Case Study Applied to the UK prospective Diabetes Study (UKPDS) Individual Patient outcome Simulation ModelAlam, M. / Briggs, A. et al. | 2011
- A235
-
PC2 Estimation of Productivity Costs Using the Friction Cost Method: New Evidence Using National DataErdogan-Ciftci, E. / Koopmanschap, M. A. et al. | 2011
- A236
-
PR3 Industry Preparedness against German reformsDevienne, E. / White, R. / Mukku, S. et al. | 2011
- A237
-
MT4 Mixed Treatment Comparisons Using Aggregate- and individual-Participant Level Data: An Efficient Use of Evidence for Cost-Effectiveness ModellingSaramago, P. / Sutton, A. J. / Cooper, N. J. / Manca, A. et al. | 2011
- A238
-
UT1 Combining DCE and TTO Into A Single Value FunctionVan Hout, B. A. / Oppe, M. et al. | 2011
- A239
-
VI3 Sequential Treatment of Follicular Non-Hodgkin Lymphoma: Cost-Effectiveness and Value of informationSoini, E. J. / Martikainen, J. A. / Vihervaara, V. / Mustonen, K. / Nousiainen, T. et al. | 2011
- A241
-
MA1 Mapping the EQ-5D Index from I-QOL in Idiopathic and Neurogenic OAB Patients: Results from A Cross-Sectional Study in the United States and Four European CountriesKay, S. / Tolley, K. / Globe, D. / Piercy, J. / Anderson, P. et al. | 2011
- A242
-
MO2 Extrapolation in Oncology Modelling: Novel Methods for Novel CompoundsAnnemans, L. / Asukai, Y. / Barzey, V. / Kotapati, S. / Lees, M. / Van Baardewijk, M. / Wang, Q. / Batty, A. J. / Fisher, D. et al. | 2011
- A243
-
RS3 Evidence, Process or Context? Examining The Factors That Drive Coverage Decisions Of Pharmaceuticals By Health Technology Assessment Bodies In EuropeCerri, K. / Ferná / ndez, J. L. / Knapp, M. et al. | 2011
- A244
-
PMD4 Expert Elicitation to Populate Early Health Economic Models of Medical Diagnostic Devices in DevelopmentHaakma, W. / Bojke, L. / Steuten, L. / Ijzerman, M. et al. | 2011
- A247
-
PMD20 Cost Analysis of Rechargeable Deep Brain Stimulator in DystoniaPr Coubes, P. / Fluck, L. / Topouchian, A. et al. | 2011
- A248
-
PMD25 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) in High-Risk or Inoperable Patients with Symptomatic Aortic Valve Stenosis in SpainFerreira-Gonzá / lez, I. / Serra, V. / Abdul, O. / Lizan, L. / Paz, S. / Banz, K. / Sureda, C. / Igual, A. / Garcia del Blanco, B. et al. | 2011
- A249
-
PMD31 Economic Evaluation of Primovist versus Extracellular Contrast in Imaging of Liver Metastases of Colorectal OriginCastell, J. / Bernal, C. / De Marcos, J. x. / Cugat, E. / Ramó / n, E. / Tellado, J. M. et al. | 2011
- A250
-
PMD37 Cost-Effectiveness of the Ex-Press Glaucoma Filtration Device in FranceDe jong, L. / Lafuma, A. / Clé / ment, O. / Aguade, A. S. / Berdeaux, G. et al. | 2011
- A251
-
PMD42 Cost-Effectiveness of Using the UGT1A1 Pharmacogenetic Test to Reduce the Incidence of Irinotecan Chemotherapy-related Febrile NeutropaeniaShabaruddin, F. H. / Elliott, R. A. / Tappenden, P. / Payne, K. et al. | 2011
- A253
-
PMD54 Resource Utilisation Related to Catheter-associated Urinary Tract infections in Swedish Spinal injury PatientsBruce, S. / Lö / froth, E. / Knutsson, B. / Bö / rstell, T. / Myré / n, K. J. et al. | 2011
- A254
-
PMD59 Complicated Parkinson'S Disease: Discrete Choice Analysis to Assess Patients' Preferences. A Pilot StudyLloyd, A. J. / Herdman, M. / Gonzalez, P. et al. | 2011
- A255
-
PMD64 The Effect of Supplementary Fees on the Diffusion of Medical Devices in the German System of Diagnosis related Groups (G-Drg): The Case of Drug-Eluting Stents in Patients with Acute Myocardial InfarctionBä / umler, M. et al. | 2011
- A257
-
PMD75 Patient Self-Testing of Oral Anticoagulation Therapy by CoaguChek® XS System. Rapid Health Technology Assessment in Slovak Health Care EnvironmentVisnansky, M. / Mesaros, S. et al. | 2011
- A258
-
PMD80 Patient Demographics and Surgical Expenditure in Hernia repair Surgical Cohorts Using A retrospective Nationwide Patient DatabaseHargreaves, J. A. / Nair, K. V. / Ghushchyan, V. H. / Allen, R. R. / Mcqueen, R. B. / Robinson, T. et al. | 2011
- A259
-
PMD85 Sleep Questionnaires Discriminate Between Participants With and Without Overactive Bladder SymptomsMargolis, M. K. / Coyne, K. / Jumadilova, Z. et al. | 2011
- A260
-
PSU5 Risk of Arthritis as A Predictor for the Misdiagnosis of Chondrolysis: An International Analysis of Clinical OutcomesSmith, J. C. / Provencher, M. T. / Solomon, D. J. / Navaie, M. et al. | 2011
- A261
-
PSU10 Economic Evaluation of Magnetic Resonance Guided Focused Ultrasound in Patients with Uterine Fibroids in GermanyAlvarez-Ossorio, L. / Burkowitz, J. / Nackunstz, I. / Brueggenjuergen, B. et al. | 2011
- A262
-
PSU15 the Economic Burden of Post-Transplant Events in Renal Transplant Patients in UK, Italy, Netherlands, Poland and BelgiumSennfalt, K. / Ling, C. / Pericleous, L. / Sbarigia, U. / Gatta, F. / Kolasa, K. / Zagorska, A. / Chamberlain, G. / Pandit, P. et al. | 2011
- A263
-
PSU21 Speech Problem and Health-Related Quality of Life in Head and Neck Cancer Survivors After Five Years of TreatmentsPayakachat, N. / Suen, J. Y. et al. | 2011
- A264
-
PSU26 Two-Year Changes in Generic and Obesity-Specific Quality of Life After Gastric BypassMar, J. / Arrospide, A. / Mar, B. / Martinez de Aragó / n, G. / Karlsson, J. et al. | 2011
- A265
-
PIN3 Comparing the Efficacy and Tolerability of Anti-Retroviral Therapy in Treatment-Naïve HIV-1 Infected Adults: A Systematic review of Randomized Clinical Trials and Bayesian Mixed Treatment Comparisons Including Atazanavir/R, Darunavir/R, Lopinavir/R, and EfavirenzVerheggen, B. / Vandeloise, E. / Treur, M. / Thuresson, P. O. / Lescrauwaet, B. et al. | 2011
- A266
-
PIN8 A Decision Tree Model Comparing Clinical Outcomes of Treatment with Telbivudine with or without “Tenofovir Add-on as Needed” and Lamivudine with or without “Tenofovir Add-on as Needed” in the Treatment of Chronic Hepatitis B Infection in TurkeyOzdemir, O. / Saylan, M. / Pakel, H. / Lescrauwaet, B. et al. | 2011
- A267
-
PIN13 Epidemiology of Staphylococcus Aureus Infections in Children: A Literature Review of the Last 10 YearsBricout, H. / Maier, W. / Mouchet, J. et al. | 2011
- A268
-
PIN18 Budget Impact Analysis of Tenofovir in Treatment of Chronic Hepatitis B (CHB)Gwiosda, B. / Krzystek, J. / Rys, P. / Wladysiuk, M. / Mierzejewski, P. / Kazmierski, M. / Plisko, R. et al. | 2011
- A269
-
PIN24 Potential Costs Associated with New Direct Acting Antiviral (DAAs) Therapy for Untreated Chronic Hepatitis C Genotype 1 Infection in the Veterans Health AdministrationChan, K. / Lai, M. N. / Groessl, E. J. / Hanchate, A. / Hernandez, L. / Wong, J. B. / Clark, J. A. / Asch, S. / Gifford, A. L. / Ho, S. et al. | 2011
- A270
-
PIN31 Quantifying the Financial and Disease Burden Associated with Mother to Child Transmission of HIV in UgandaKuznik, A. / Semeere, A. / Sempa, J. / Auerbach, B. / Lamorde, M. / Castelnuovo, B. / Hermans, S. / Ssewankambo, F. / Ssennono, M. / Mpanga Sebuyira, L. et al. | 2011
- A271
-
PIN36 Surgical Site Infection Incidence and Burden Assessment Using Multi-Institutional Real-World DataDelissovoy, G. / Pan, F. / Patkar, A. D. / Edmiston, C. E. / Peng, S. et al. | 2011
- A272
-
PIN41 Cost-Benefit Analysis of Regional Procured Essential Medicines in the Southern African Development Community (SADC) with a Focus on Access to Antiretroviral DrugsMiller-Jansö / n, H. E. / Stander, M. et al. | 2011
- A274
-
PIN53 Cost-Effectiveness Analysis of Pegylated Interferon Alpha-2A Versus Pegylated Interferon Alpha-2B in the Treatment of Chronic Hepatitis C Patients in PolandMacioch, T. / Paweska, J. / Niewada, M. / Berak, H. / Szkultecka-Debek, M. / Russel-Szymczyk, M. et al. | 2011
- A275
-
PIN58 Cost-Effectiveness Analysis of Pneumococcal 13-Valente Conjugate Vaccine Versus Pneumococcal 10-Valente Conjugate Vaccine in the Pediatric Immunization Routine, from the São Paulo State Public Health Care System (Brazil)Pepe, C. / Teich, V. / Mould, J. F. et al. | 2011
- A276
-
PIN63 Cost-Effectiveness Analysis of Anti-Pneumococcal Vaccines in PanamaLutz, M. A. / Luciani, K. / Morales, G. / Strutton, D. R. / Roberts, C. S. / Farkouh, R. A. / Cuesta, G. et al. | 2011
- A277
-
PIN68 Cost- Effectiveness Analysis of Human Papillomavirus Vaccination Program in RussiaOmelyanovsky, V. / Avxentyeva, M. / Krysanov, I. / Ivakhnenko, O. / Goryaynov, S. / Tsfasman, F. M. et al. | 2011
- A278
-
PIN73 Modeling the Long Term Clinical Outcomes and Health Care Cost Impact of Initiating Treatment with Atazanavir/R Compared with Darunavir/R, Lopinavir/R and Efavirenz for HIV-1 Infected Treatment-NaÏve Patients: Country Results for Italy, Spain, Portugal and UKThuresson, P. O. / Verheggen, B. / Heeg, B. / Aldir, I. / Carrasco, J. / Didoni, G. / Mesa, O. A. / Lescrauwaet, B. et al. | 2011
- A279
-
PIN78 Cost Utility of Infant Vaccination Against Respiratory Syncytial Virus Infection in the NetherlandsMeijboom, M. / Rozenbaum, M. / Benedictus, A. / Luytjes, W. / Kneyber, M. / Wilschut, J. / Hak, E. / Postma, M. et al. | 2011
- A280
-
PIN83 Cost-Effectiveness and Cost-Utility analysis of 200 Days Prophylaxis of Cytomegalovirus (CMV) infections in High Risk (D+/R-) Kidney Transplant Recipients in PolandKawalec, P. / Holko, P. / Boratynska, M. / Glyda, M. / Ignacak, E. / Russel-Szymczyk, M. / Szkultecka-Sebek, M. / Kaweczynska-Lason, A. et al. | 2011
- A282
-
PIN94 Assessment of Health Related Quality of Life (HRQOL) in Hepatitis- B PatientsHaq, N. / Shafie, A. A. / Hassali, M. A. / Ibrahim, M. I. / Saleem, F. et al. | 2011
- A283
-
PIN99 Modelling the Impact of Extended Vaccination Strategies on the Epidemiology of PertussisRozenbaum, M. H. / De vries, R. / Postma, M. J. / Le, H. H. et al. | 2011
- A284
-
PIN105 Financial Support for HIV/AIDS Prevention, Care and Treatment in ThailandLayton, M. R. / Pachanee, K. / Prakongsai, P. et al. | 2011
- A285
-
PIN110 Development of A Large Safety Database Using Studies Conducted During the Clinical Development and Post-Marketing of A Virosomal Aluminium-Free Hepatitis A VaccineFaure, C. / Koller, A. / Hartmann, K. / Chré / tin, S. / Doux, S. / Visè / le, N. / Bugnard, F. / Maier, W. et al. | 2011
- A286
-
PMH2 The Efficacy of the New Antidepressant Agomelatine as Compared Against Placebo and SSRIS: A Meta-Analysis Combining Published and Unpublished DataBallesteros, J. / Tarapues, M. / Santos, B. / Rueda, J. R. et al. | 2011
- A287
-
PMH7 Aasenapine Versus Other Antipsychotics in Bipolar I Disorder: Indirect Comparisons at Twelve WeeksSapin, C. / Corson, H. / Beillat, M. / Hansen, K. et al. | 2011
- A288
-
PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral OlanzapineNovick, D. / Ascher-Svanum, H. / Bertsch, J. / Detke, H. / Mcdonnell, D. / Witte, M. / Haro, J. et al. | 2011
- A289
-
PMH17 The Economic and Social Consequences of Schizophrenia Treatment with Seroquel XR® (Quetiapine Prolonged Release Tablets) in Poland: Aanalysis of the Impact on the Health Care SystemFaluta, T. / Rdzanek, M. / Pierzgalska, K. / Wró / bel, B. et al. | 2011
- A290
-
PMH23 The Economic Burden of Mental Ill Health in the Workplace: A Costing Approach for Brazilian EmployersReis, T. C. / Takemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Cukier, F. N. / Santos, P. M. / Cruz, R. B. / Ribeiro, A. C. / Fernandes, R. R. et al. | 2011
- A291
-
PMH29 Cost Effectiveness of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Turkey in Patients with Major Depressive Disorder (Mdd) Who Have Failed Previous Antidepressant TherapyAydemir, O. / Dilbaz, N. / Malhan, S. et al. | 2011
- A292
-
PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in NorwayEinarson, T. R. / Vicente, C. / Zilbershtein, R. / Piwko, C. et al. | 2011
- A293
-
PMH40 Economic Evaluation of Agomelatine for Major Depressive Disorder in AustraliaO'Leary, B. A. / Hamann, G. B. / Adena, M. A. et al. | 2011
- A294
-
PMH46 The Quality of Life of Children With ADHD and their Parents: Results of EQ-5D and Kidscreen-10Van Der Kolk, A. / Bouwmans, C. / Schawo, S. / Buitelaar, J. B. / van der Gaag, R. J. / Van agthoven, M. / Hakkaart-van Roijen, L. et al. | 2011
- A295
-
PMH51 Measuring Relapse After Substance Abuse Treatment: A Proportional Hazard ApproachCiesla, J. / Mazurek, K. et al. | 2011
- A296
-
PMH56 Negative Symptoms Have Greater Impact on Functioning Than Positive Symptoms in Schizophrenia: Analysis of Catie DataRabinowitz, J. / Garibaldi, G. / Levine, S. / Bugarski-Kirola, D. / Berardo, C. / Kapur, S. et al. | 2011
- A297
-
PMH61 A Descriptive Analysis of Atomoxetine Utilization in Attention Deficit/Hyperactivity Disorder (ADHD) the United Kingdom and ItalySikirica, V. / Mitra, D. / Fridman, M. / Davis, K. L. / Hodgkins, P. et al. | 2011
- A298
-
PMH66 12-Year Trend Analysis on the Characteristics, Primary Payer, and Prescribed Medications of Physician-Office Visits for Patients with Dementia in the United StatesChen, Y. J. / Sankaranarayanan, J. / Murman, D. L. et al. | 2011
- A300
-
PMH77 Prescription Pattern Evaluation for Bipolar Disorder in a Treatment Facility in IndiaNagappa, A. N. / Kumar, M. / Noorunnisa, S. / Bhandary, P. V. / Veerupaksh, D. / Balakrishnan, R. et al. | 2011
- A301
-
PMH83 Estimating Utilities in Schizophrenic and Bipolar Patients from Disease-Specific or Generic Instruments Assessing Patients' Health States: Where are the Differences?Cuervo, J. / Rebollo, P. / Maurino, J. / Cordero, L. / Castejó / n, N. et al. | 2011
- A303
-
PMS10 Evaluation the Risk Factors of Second Hip Fractures in the ElderlySebestyé / n, A. / Sá / ndor, J. / Patzai, B. / Gõ / cze, K. / Kriszbacher, I. / Mintá / l, T. et al. | 2011
- A304
-
PMS15 Costs of Tumor Necrosis Factor Blockers per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured PopulationSchabert, V. / Gandra, S. R. / Watson, C. / Fox, K. M. / Yeaw, J. / Goodman, S. / Milev, S. / Harrison, D. J. et al. | 2011
- A305
-
PMS20 Treatment of Patients with Moderate and Severe Psoriasis – Cost-of-Illness in the Czech RepublicPetrikova, A. / Klimes, J. / Dolezal, T. / Marinov, L. / Petrova, G. et al. | 2011
- A307
-
PMS31 Cost-Effectiveness of Abatacept for the Treatment of Rheumatoid Arthritis (RA) After the Failure of a First TNF inhibitor in the United KingdomPericleous, L. / Lebmeier, M. et al. | 2011
- A308
-
PMS36 Economic Analysis of Etanercept in Rheumatoid Arthritis from a Public perspective in ColombiaFernandes, R. A. / Tovar, D. A. / Mould, J. F. et al. | 2011
- A309
-
PMS41 Assessing the Cost Effectiveness of Broadening Access to Alendronate for the Prevention of Osteoporotic Fracture in AustraliaTilden, D. / Jackson, D. / Tay-Teo, K. / Van Bavel, J. et al. | 2011
- A310
-
PMS46 Cost-Utility Analysis of Certolizumab Pegol versus Alternative Tumor Necrosis Factor-Inhibitors, for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in SpainVilloro, R. / Hidalgo, A. / Ferro, B. / Talavera, P. et al. | 2011
- A311
-
PMS51 A Cost Utility Analysis of Anti-TNF Agents for the Treatment of Rheumatoid ArthritisAdams, R. C. / Walsh, C. / Schmitz, S. / Barton, P. / Barry, M. et al. | 2011
- A312
-
PMS56 Subjective Health Expectations of Rheumatoid Arthritis Patients Starting Biological TherapyGulacsi, L. / Brodszky, V. / Baji, P. / Gulacsi, L. x. / Pé / ntek, M. et al. | 2011
- A314
-
PMS67 Determining the True Impact of Dupuytren'S Disease: A Qualitative StudyWilburn, J. / McKenna, S. / Crawford, S. R. / Perry-Hinsley, D. / Bayat, A. et al. | 2011
- A315
-
PMS72 Assessment of Prior Use of Prescribed Pain Medications Among Elderly Patients Who Initiated DuloxetineChen, S. Y. / Peng, X. / Wu, N. / Bernauer, M. / Rao, P. / Boulanger, L. / Zhao, Y. et al. | 2011
- A316
-
PMS77 Improving Quality and Reducing Costs in Workers' Compensation Health Care: A Population-Based Intervention StudyWickizer, T. M. / Franklin, G. M. / Fulton-Kehoe, D. et al. | 2011
- A317
-
PND3 Risk-Benefit Analysis of Therapy in Multiple SclerosisQizilbash, N. / Mé / ndez, I. / Sá / nchez-de la Rosa, R. et al. | 2011
- A318
-
PND9 The Role of Spontaneous Events Databases for Benefit-Risk AnalysisQizilbash, N. / Mé / ndez, I. / Sá / nchez-de la Rosa, R. et al. | 2011
- A319
-
PND14 Comparing Expected Costs associated with Three Screening Strategies for Cystic Fibrosis Along SpainRamos-Goñ / i, J. M. / Valcá / rcel-Nazco, C. / Castilla-Rodrí / guez, I. / Espada-Sá / enz-Torre, M. / Tellerí / a-Orriols, J. J. et al. | 2011
- A320
-
PND20 A Cost-of-Illness Analysis Of Amyotrophic Lateral Sclerosis In GreeceAthanasakis, K. / Sideris, M. / Zacharis, M. / Rentzos, M. / Evdokimidis, I. / Kyriopoulos, J. et al. | 2011
- A321
-
PND25 Use of Drug Reimbursement as Markers of Disease for Epidemiological and Direct Cost analysis: The Case of Epilepsy in FranceFagnani, F. / Kusnik-Joinville, O. / de Zé / licourt, M. / Levy-Bachelot, L. / Branchoux, S. / Murat, C. / Bertrand, M. / Kahane, P. et al. | 2011
- A322
-
PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) DeficiencyTilden, D. / Cottrell, S. / Tocchini, L. / Jayaram, N. / Sinani, R. / Barnes, D. et al. | 2011
- A323
-
PND36 Factors Associated with Utility and Disutility Values in Relapsing Form of Multiple Sclerosis (RMS) Patients Using Data from Temso, A Teriflunomide Pivotal Phase III TrialO' / Connor, P. / Briggs, A. / Carita, P. / Bego-Le-Bagousse, G. et al. | 2011
- A324
-
PND41 Predicting EQ-5D Utility Scores from the Huntington quality of Life instrument (H-QOL-I)Clay, E. / Briquet, B. / Aballea, S. / Maman, K. / Toumi, M. et al. | 2011
- A325
-
PND46 The Huntington Quality of Life Instrument (H-QOL-I): Cross-Cultural Validation in Germany, Poland and USAClay, E. / Mraidi, M. / Zielonka, D. / Cohen, J. / Toumi, M. / Auquier, P. et al. | 2011
- A326
-
PND51 The Relationship Between Patient-Reported Health-Related Quality of Life and Disability Status Among Patients with Multiple SclerosisKhalaf, K. M. / Globe, D. / Armstrong, E. / Malone, D. / Coyne, K. et al. | 2011
- A327
-
PND56 Quality of Life Assessments in Adults with Attention Deficit/Hyperactivity Disorder - A Systematic ReviewMarfatia, S. / Shroff, K. / Munshi, S. / Tiwari, A. et al. | 2011
- A328
-
PND61 Impact of Patient Cost-Sharing Arrangements for Disease Modifying Therapies on Treatment Compliance among Patients with Multiple Sclerosis in the United StatesPalmer, L. A. / Fowler, R. / Shi, N. / Dastani, H. / Abouzaid, S. / Kim, E. et al. | 2011
- A329
-
PND66 Cross-Cultural Adaptation and Validation of the Brazilian Version of the Fatigue Severity Scale (FSS)Toledo, F. O. / Junior, W. M. / Speciali, J. G. / Sobreira, C. F. et al. | 2011
- A330
-
PUK3 Sources of Heterogeneity Among Overactive Bladder Clinical Trial Estimates of Tolterodine and Fesoterodine Reductions of Urgency Urinary Incontinence Episodes Relative to PlaceboSnedecor, S. J. et al. | 2011
- A331
-
PUK9 Comparative Cost Analysis of Treatment for Renal Anemia with Methoxy Polyethylene-Glycol Erythropoietin Beta (MIRCERA®) Versus Erythropoietin Beta (NEORECORMON®)Medina Gó / mez, J. L. et al. | 2011
- A332
-
PUK14 Trends in Rate and Cost of Hospitalizations Due to Chronic Kidney Disease (CKD) in the United StatesAggarwal, S. et al. | 2011
- A333
-
PHP3 Patient Preferences Considering the Choice of Health Care Providers in Hungary – Results From Discrete Choice ExperimentBaji, P. / Pavlova, M. / Gulacsi, L. / Groot, W. et al. | 2011
- A334
-
PHP9 Temporary Use Authorizations: The Economic and Clinical Future of Drugs Used in the French Compassionate ProgramDegrassat-Thé / as, A. / Paubel, P. / Parent de Curzon, O. / Le Pen, C. / Sinè / gre, M. et al. | 2011
- A335
-
PHP14 Multiple Indication Pricing, Reimbursement and Funding Dynamics: The Case of Orphan IndicationsWild, L. / Forster, L. et al. | 2011
- A336
-
PHP21 Adoption of New Medicines in the OECD: Regulation, Innovation and ScaleVarol, N. / Costa-i-Font, J. / Mcguire, A. J. et al. | 2011
- A337
-
PHP26 Health Outcomes and Economics Research for Regenerative Medicine and Cellular Therapies: Lessons From A Multi-Market Health Technology Assessment and Reimbursement reviewFaulkner, E. C. / Fernandez, M. / Spinner, D. S. et al. | 2011
- A338
-
PHP31 The Economic Impact of Switches of Prescription Drugs to the Over-the-Counter Status (Rx-to-OTC): A Systematic Literature ReviewKarray, S. M. / Plich, A. / Flostrand, S. / Toumi, M. et al. | 2011
- A339
-
PHP37 Regional Drug Evaluation in Spain: A Comparison Among CommitteesHerná / ndez-Pastor, L. J. / Huerta, A. et al. | 2011
- A340
-
PHP42 Drug Consumption in Bosnia and Herzegovina - Comparison to Neighboring CountryKrehic, J. / Gavrankapetanovic, F. / Djapo, M. / Agic, N. et al. | 2011
- A341
-
PHP48 Croatian Pharmaceutical Expenditure Before and After Healthcare Reform – Comparison to EU CountriesPogorilic, S. / Vitezica, P. / Bolanca, S. et al. | 2011
- A342
-
PHP54 Predictors of Avoidable Emergency Room Visits Among High Cost Medicaid EnrolleesGanduglia, C. / Franzini, L. / Dunn, K. et al. | 2011
- A343
-
PHP59 Estimation of Increases in Direct Medical Expenditures Associated with Medication Nonadherence and Potential Savings from Increased AdherenceHicks, K. A. / Karve, S. J. / Vlahiotis, A. / Frazee, S. G. / Tian, Y. / Earnshaw, S. R. et al. | 2011
- A344
-
PHP64 Reorganisation of Hospital Emergency Services: A Business Case for Quality ImprovementEichler, K. / Senn, O. / Rü / themann, I. / Bö / gli, K. / Sidler, P. / Brü / gger, U. et al. | 2011
- A345
-
PHP70 Value Based Pricing (VBP): Is This the Way Forward for the UK NHS?Comberiati, U. / Dass, R. N. / White, N. et al. | 2011
- A346
-
PHP75 The Cost Per Day of Intensive Care Units (ICU) in France: The CRRÉA StudyGarrigues, B. / Lefrant, J. Y. / Bazin, J. / Bardoulat, I. / Tagdichti, K. / Courtial, F. / Maurel, F. / Pribil, C. et al. | 2011
- A347
-
PHP80 Where A Cheap Medicine is Not the Same as A Generic Medicine: The Belgian CaseDylst, P. / Vulto, A. / Simoens, S. et al. | 2011
- A348
-
PHP86 Incorporating the Patient Perspective Into the Health Care Process: Experience from the C.A.T. Health SystemRebollo, P. / Castejó / n, N. / Cuervo, J. / Igarreta, M. / Ortega, F. et al. | 2011
- A349
-
PHP92 Lack of Clinical Efficacy as a Main Reason for Ahtapol Negative Recommendations for Orphan Oncology DrugsOfierska-Sujkowska, G. / Jagodzinska-Kalinowska, K. / Matusewicz, W. / Pasierski, T. et al. | 2011
- A350
-
PHP97 Use of Paediatric “Observation Status” and Effect on in-Patient Admission Rate in Accident and Emergency (A&E) DepartmentsLaokri, S. / Zhang, W. H. / Ben Hamed, N. / Cohen, L. / De Wever, A. / Alexander, S. et al. | 2011
- A351
-
PHP103 Global Health Care Reforms and Pricing, Access and Health Outcomes StrategyAggarwal, S. et al. | 2011
- A352
-
PHP108 Public Health and Prevention in Europe: Is it Cost-Effective?Simoens, S. et al. | 2011
- A353
-
PHP113 Measuring the Organizational Performance in Tennessee: A Case of Community HospitalsRoh, C. Y. / Shirore, R. M. et al. | 2011
- A354
-
PHP119 Is There No Optimal Approach for Orphan Drugs to Patient Access? Rare Disease is Not Rare and Needs to Develop the New Pricing and Reimbursement SolutionKim, S. / Cho, Y. / Shim, S. / Lee, J. / Kim, W. / Bae, K. et al. | 2011
- A355
-
PHP124 Personalized Decision Making in Cancer Medicine? Systematic Overview of HTA Procedures and Specific Approaches in Ten Countries Across Four ContinentsSchwarzer, R. / Rochau, U. / Mü / hlberger, N. / Jahn, B. / Sroczynski, G. / Schnell-Inderst, P. / Schall, I. / Kallinger, S. / Lackner, M. et al. | 2011
- A356
-
PHP129 Societal Preferences for Health Technology Disinvestment Policy: Views of Scottish Taxpayers – A Qualitative StudyHislop, J. M. et al. | 2011
- A357
-
PHP134 Comparison of the Knowledge in Standard Treatment Guidelines among Medical Practitioners and Medical StudentsHettihewa, L. M. / Wimalasena, G. / Tharanga, D. et al. | 2011
- A359
-
PHP146 Current Status and Trends in Performance-Based Schemes Between Health Care Payers and ManufacturersCarlson, J. J. / Gries, K. / Sullivan, S. D. / Garrison, L. et al. | 2011
- A360
-
PHP151 Evidence on the Impact of Managed Entries on Payers, Patients, Manufacturers, and Health Care WorkersFerrario, A. / Nicod, E. / Kanavos, P. et al. | 2011
- A361
-
PHP157 Using the CEAC for Value Based Pricing: Don'T Change the GoalpostsRoberts, G. et al. | 2011
- A363
-
PHP168 Endogenous Cost-Effectiveness Analysis in Health Care Technology AdoptionJena, A. B. / Philipson, T. J. et al. | 2011
- A364
-
PCV5 Thromboembolisms with Thrombopoietin Receptor Agonists: Systematic Review and Meta-Analysis of Randomized Controlled TrialsCorrales-Á / lvarez, I. / Catalá / pez, F. / Martí / n-Serrano, G. / Montero-Corominas, D. / Calvo-rojas, G. et al. | 2011
- A366
-
PCV15 Guidelines Adherence and Hypertension Control in Patients Suffering from Cardiovascular DiseaseAhmad, N. / Hassan, Y. / Tangiisuran, B. / Meng, O. L. / Aziz, N. A. / Saleem, F. / Atif, M. et al. | 2011
- A367
-
PCV19 Prescription of Angiotensin Converting Enzyme Inhibitors and Hypertension Control in Diabetic Hypertensive PatientsAhmad, N. / Hassan, Y. / Tangiisuran, B. / Meng, O. L. / Aziz, N. A. / Saleem, F. / Atif, M. et al. | 2011
- A368
-
PCV25 Characterising Patients with A First-Time Admission for atrial Fibrillation in the United KingdomJones, J. / Townsend, R. / Jameson, K. / Amber, V. / Evans, L. M. et al. | 2011
- A370
-
PCV37 Parametric Conditional Non-Frailty Model for Recurrent Events in Persons with Type 2 Diabetes in Sweden: The Example of Myocardial InfarctionAhmad Kiadaliri, A. / Clarke, P. M. / Gerdtham, U. G. / Nilsson, P. / Eliasson, B. / Gudbjö / rnsdottir, S. / Steen carlsson, K. et al. | 2011
- A371
-
PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in SpainDarba, J. / Kaskens, L. / Nilsson, J. / Oberdiek, A. et al. | 2011
- A372
-
PCV47 Analysis of Transient Ischemic Attack-Related Clinical Outcomes, Health Care Utilization and Cost Burden of Patients with Non-Valvular Atrial FibrillationBaser, O. / Wang, L. et al. | 2011
- A373
-
PCV53 Cost Study of Caregiving for Patients with Chronic Symptomatic Heart Failure in Spain, Insights from the Inoescaro StudyMarti, B. / Delgado, J. / Oliva, J. / Llano, M. / Pascual, P. / Comin, J. / Grillo, J. J. / Diaz molina, B. / Culebras, J. / Martí et al. | 2011
- A376
-
PCV70 Cost Effectiveness of Ticagrelor in the Treatment of Acute Coronary Syndrome in GermanyTheidel, U. / Asseburg, C. / Giannitsis, E. / Katus, H. et al. | 2011
- A377
-
PCV76 A Cost-Effectiveness Analysis of Clopidogrel in Patients with Non Stable Acute Coronary Syndrome in GreeceKourlaba, G. / Fragoulakis, V. / Maniadakis, N. et al. | 2011
- A378
-
PCV81 Cost-Effectiveness of Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndrome: Results from the Plato Study: A Canadian AnalysisMittmann, N. / Chan, B. / Seung, S. J. / Liovas, A. / Cohen, E. et al. | 2011
- A379
-
PCV86 Long-Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome (ACS) from A Mexican Public and Private Health Care Perspective Based on Data from the Plato TrialGarcia-Castillo, A. / De-los-Rios, M. / Polanco, A. C. / Ramirez, M. A. / Nikolic, E. / Mellströ / m, C. et al. | 2011
- A380
-
PCV91 Cost-Effectiveness of Endovascular Treatment Versus Open Surgery in Patients with Steno-Occlusive Disease of the Femoral ArteryRamos-Goñ / i, J. M. / Mar-Medina, J. / Valcá / rcel-Nazco, C. / Castilla-Rodrí / guez, I. et al. | 2011
- A382
-
PCV102 Evaluation of the Measurement Properties of the Antihypertensive Adherence SurveyHudgens, S. / Lynch, J. / Pasquale, K. / Zacker, C. et al. | 2011
- A383
-
PCV107 Correlation of Physician-Rated Adherence with Therapeutical Outcomes in Antihypertensive Treatment: Pooled Analysis Findings from Six Valsartan Studies Including 15,583 Available PatientsVilla, L. / Abraham, I. / Macdonald, K. / Denhaerynck, K. et al. | 2011
- A384
-
PCV112 A Comparison of European Health Care Systems on Stroke Prevention in Atrial Fibrillation – Interim Results of a Patient Satisfaction SurveyOberdiek, A. / Sandberg, A. / Franczok, E. et al. | 2011
- A386
-
PCV123 The Participation Decision for Lifestyle Disease ScreeningSø / gaard, R. / Lindholt, J. / Gyrd-Hansen, D. et al. | 2011
- A387
-
PCV128 A Real World Evaluation to Describe the Characteristics, Outcomes and Resource Use Associated with Patients Being Managed by a Secondary Care Based Anticoagulation ServiceRose, P. / James, R. / Chapman, O. / Marshall, S. et al. | 2011
- A388
-
PCV134 Concomitant Medciation Use in US Adults on Statin Therapy: Findings from a Multi-Employer Claims DatabaseMolife, C. / Zhu, Y. / Yu, C. / Mccracken, R. / Zhao, Z. et al. | 2011
- A389
-
PCV139 Epidemiology and Economic Burden of Atrial Fibrilation to the Public Health Care System in BrazilNasciben, V. / Piegas, L. S. / Figueiredo, M. J. / Martins, S. C. et al. | 2011
- A391
-
PGI2 The Relationship Between Acute and Chronic Acetaminophen Exposure and Liver ToxicityGokhale, M. N. / Foster, H. R. / Cleves, M. / Hogan, W. R. / James, L. P. / Martin, B. et al. | 2011
- A392
-
PGI7 Impact of Complications from Dysphagia on Hospital Charges in the United StatesJensen, I. S. / Helm, T. / Cyr, P. L. et al. | 2011
- A393
-
PGI13 Evaluation of the Clinical and Economic Burden of Chronic Constipation in BelgiumLeeuwenkamp, O. / Chevalier, P. / Lamotte, M. et al. | 2011
- A394
-
PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS SettingAreias, J. / Branco, T. / Calinas, F. / Carvalho, A. / Macedo, G. / Manata, M. J. / Matos, L. / Rodrigues, B. / Velosa, J. / Pereira, C. et al. | 2011
- A395
-
PGI23 Economic Impact of Medication Adherence and Persistence in the Treatment of Ulcerative Colitis in Canada: Analyses with the Ramq DatabaseLachaine, J. / Yen, L. / Beauchemin, C. / Hodgkins, P. et al. | 2011
- A396
-
PGI28 Disease-Specific Health-related Quality of Life in Patients with Quiescent Ulcerative Colitis: Effects of one Year Maintenance Treatment with MMX MesalamineSolomon, D. / Yarlas, A. / Yen, L. / Hodgkins, P. / Karlstadt, R. / Kane, S. V. et al. | 2011
- A397
-
PGI33 Predictors of Direct Medical Costs of Crohn'S Disease and Ulcerative ColitisStark, R. G. / Hunger, M. F. / Reitmeir, P. / Kö / nig, H. H. / Leidl, R. et al. | 2011
- A398
-
PIH5 Respiratory Syncytial Virus (RSV) Prophylaxis in Special PopulationsPaes, B. A. / Li, A. / Lanctot, K. L. / Mitchell, I. et al. | 2011
- A399
-
PIH12 Patients with BPH in France: Results at Six Months with Phytotherapy Versus Other TreatmentsPerrin, P. / Auges, M. / Rahhali, N. / Taieb, C. et al. | 2011
- A400
-
PIH18 Rotavirus Gastroenteritis in Vulnerable Children: A UK Case Control StudyPockett, R. D. / Campbell, D. / Adlard, N. E. / Rajoriya, F. / Carroll, S. M. et al. | 2011
- A401
-
PIH23 Cost-Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Psychostimulant Compared to Psychostimulant Monotherapy for the Treatment of Attention Deficit/Hyperactivity Disorder in Children and AdolescentsSikirica, V. / Erder, M. / Xie, J. / Macaulay, D. / Diener, M. / Hodgkins, P. / Wu, E. Q. et al. | 2011
- A402
-
PIH28 Economic Evaluation of Pneumococcal Conjugated Vaccines for ArgentinaEllis, A. / Lepetic, A. C. / Gomez, J. A. et al. | 2011
- A403
-
PIH34 Patient Reported Reasons for Medication Nonadherence: A SurveyLee, K. / Nixon, M. / Cascade, E. / Plummer, C. / Law, V. / Lee, M. et al. | 2011
- A405
-
PIH45 Burden of Herpes Zoster and Post-Herpetic Neuralgia: Findings from a Cross-Sectional Patient Reported Outcomes StudyCarroll, S. / Gater, A. / Abetz, L. / Demuth, D. / Smith, F. / Mannan, A. et al. | 2011
- A406
-
PIH50 quality of Life of Students from the Faculty of Pharmacy at Medical University of Warsaw in 2011Zawodnik, S. / Kiljan, A. / Hermanowski, T. / Golicki, D. et al. | 2011
- A408
-
PIH62 Comparative Pricing and Reimbursement Analysis in Four East European CountriesPeev, S. / Petrova, G. / Baran, A. / Petrikova, A. / Daneasa, D. et al. | 2011
- A409
-
PIH67 Successful Development of Annual and Long Term Prediction Models to Estimate Height Outcome following Growth Hormone (GH) Therapy in Children Using Data from KIGS – A Large Pharmacoepidemiological SurveyLoftus, J. / Ranke, M. / Lindberg, A. / Brosz, M. / Kaspers, S. / Wollmann, H. / Koltowska-Haggstrom, M. / Roelants, M. et al. | 2011
- A410
-
PSY4 Comparison of Infliximab and Ustekimumab for Treatment of Moderate to Severe Psoriasis: a Mixed Treatment Meta-AnalysisFan, T. / Bennett, H. / Smith, N. / Marin, M. / Sen, S. et al. | 2011
- A412
-
PSY15 Striving for Affordable Treatments Within the Greek Environment: Do Epoetin Biosimilars Help?Kani, C. / Litsa, P. / Alexopoulou, E. / Hatzikou, M. / Delibasi, S. / Geitona, M. et al. | 2011
- A413
-
PSY20 The Annual Direct Medical Cost of Systemic Lupus Erythematosus (Sle) Patients and Costs Drivers (Lucie Study): French ResultsAmoura, Z. / Pennaforte, J. L. / Hamidou, M. / Arfi, S. / Lazaro, E. / Hachulla, E. / Pourrat, J. / Queyrel, V. / Aubin, C. / Garofano, A. et al. | 2011
- A414
-
PSY25 What is the Economic Impact of Obesity on Hospital Inpatient Care?Pereira, J. / Ribeiro, V. / Mateus, C. et al. | 2011
- A415
-
PSY31 Cost-Effectiveness of Tapentadol Prolonged-Release (Pr) Compared to Oxycodone Controlled Release (Cr) in Patients with Chronic Severe Non-Cancer Pain in IrelandObradovic, M. / Ikenberg, R. / Hertel, N. / Liedgens, H. et al. | 2011
- A416
-
PSY36 Modelling the Cost-Effectiveness of Orlistat as a Treatment for Obesity in Primary CareAra, R. / Blake, L. et al. | 2011
- A417
-
PSY42 Chronic Pain: Patient Treatment Preferences - a Discrete Choice ExperimentMü / hlbacher, A. / Ezernieks, J. / Nü / bling, M. et al. | 2011
- A418
-
PSY47 Evaluating the Cross-over Effect on Health-related Quality of Life in a Randomized Cross-over Study of Hemophilia-A PatientsJo, H. / Gringeri, A. / Leissinger, C. / Mantovani, L. / Cortesi, P. / Gemmen, E. et al. | 2011
- A419
-
PSY53 Changes in Concomitant therapy for Weight-related Illness Following Initiation of Weight Loss PharmacotherapyAgatep, B. C. / Charland, S. L. / Herrera, V. / Hawk, G. / Stanek, E. J. et al. | 2011
- A420
-
PSY58 Responsiveness of the Treatment Satisfaction with Medicines Questionnaire (Satmed-Q) in a Longitudinal Sample of Patients with Neuropathic PainRejas, J. / Ruiz, M. A. / Pardo, A. / Ruiz, L. / Soto, J. et al. | 2011
- A421
-
PRM5 Novel Patient Reported Outcomes and Data Tool for Chronic Disease Management (PROCDIM): Case in Point Prostate CancerAggarwal, S. et al. | 2011
- A422
-
PRM11 Learning Effect in Economic Evaluations of Health Care InterventionsChang, S. / Sungher, D. / Diamantopoulos, A. et al. | 2011
- A423
-
PRM17 Suitability of CLAD-CQR Models for Obtaining QALYsCunillera, O. / Vilagut, G. / Medina, A. / Tresserra, R. / Alonso, J. / Brugulat, P. / Garcí / a, C. / Ferrer, M. et al. | 2011
- A424
-
PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained ResourcesJahn, B. / Rochau, U. / Mü / hlberger, N. / Sroczynski, G. / Conrads-Frank, A. / Siebert, U. et al. | 2011
- A425
-
PRM27 Modelling the Brazilian Extended Consumer Price Index for Pharmaceutical Products: Comparison Between Exponential Smoothing and Box-Jenkins MethodsSantos, P. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Takemoto, M. M. / Fernandes, R. R. / Padula, A. C. / Cukier, F. N. / Cruz, R. B. et al. | 2011
- A426
-
PRM33 Systematic Review of Health State Utilities in SpainGarcí / a-Pé / rez, L. / Aguiar-Ibá / ez, R. / Linertová / R. / Rivero-Santana, A. / Abá / solo-Alessó et al. | 2011
- A428
-
PRM44 The First Research: Assessment of the WTP Threshold for QALY by Contingent Valuation Method in RussiaZelenova, O. et al. | 2011
- A429
-
PRM49 Evaluation of Bivariate Meta-analysis Methods to Synthesise Results of Several Studies with Two Correlated EndpointsAballea, S. / Vataire, A. L. / Neine, M. E. / Le coroller, G. / Toumi, M. et al. | 2011
- A430
-
PRM55 A New Approach to Modeling Cancer Recurrence and Follow-UpRose, J. / Augestad, K. M. / Cooper, G. / Meropol, N. J. et al. | 2011
- A431
-
PRM60 Assessing Relative Clinical Value Across Tumor Types in Metastatic DiseaseKarweit, J. / Nanavati, S. / Van Baardewijk, M. / Wagner, S. / Kotapati, S. et al. | 2011
- A432
-
PRM66 Comparison of Reconciliation and Review Methodologies for the Translation of Patient Reported Outcome (PRO) MeasuresVerjee-Lorenz, A. / Two, R. / Clayson, D. / Miller, F. et al. | 2011
- A433
-
PCN3 Cetuximab for the First-Line Treatment of Metastatic Colorectal CancerUbago, R. / Castillo, M. A. / Flores, S. / Rodriguez, R. / Beltran, C. et al. | 2011
- A434
-
PCN8 Incidence, Predictive Factors, and Infection Complications of Prolonged Neutropenia in R-CHOP/CHOP Treated Diffuse Large B-Cell Lymphoma PatientsZhou, K. R. / Kei, K. M. / Ng, H. M. / Wong, R. S. et al. | 2011
- A435
-
PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase: Five-Years Follow-up Simulated CohortDarba, J. / Perez-Alvarez, N. / Kaskens, L. / Martin, P. et al. | 2011
- A437
-
PCN23 Survival Analyses Adjusted for Crossover in Relapsed Multiple Myeloma: Results of the Apex TrialPacou, M. / Gauthier, A. / Abrams, K. / Spencer, M. et al. | 2011
- A438
-
PCN29 Budgetary Impact of Adoption of Erlotinib for Lung Cancer in the Private Health Insurance Market in Brazil: A Real World Data AnalysisClark, O. / Clark, L. G. / Botrel, T. E. / Medina, P. / Paladini, L. / Rosa, B. / Rodrigues, N. / Fortes, A. F. / Castro, A. P. / Faleiros, E. et al. | 2011
- A439
-
PCN34 Cost Analysis of Anemia Treatment with Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in ItalyDuran, A. / Spaepen, E. / Lamotte, M. / Lucioni, C. / Kutikova, L. / Pujol, B. / Gozzo, M. / Annemans, L. et al. | 2011
- A440
-
PCN39 Burden of Brain Metastasis in an Metastatic Non-Small Cell Lung Cancer (NSCLC) PopulationGanguli, A. / Henk, H. / Teitelbaum, A. / Ray, S. et al. | 2011
- A442
-
PCN50 First and Second Line Lung Cancer Treatment Utilization Patterns and associated Costs in A United States Health Care Claims DatabaseRamsey, S. / Henk, H. / Sullivan, J. / Teitelbaum, A. / Akhras, K. / Sollano, J. / Smith, G. / Chen, C. et al. | 2011
- A443
-
PCN55 The Economic Burden of Adjuvant Chemotherapy in GermanyEiermann, W. / Rezai, M. / Kuemmel, S. / Kü / hn, T. / Benkow, A. / Hogberg, D. / Schweikert, B. / Blohmer, J. U. et al. | 2011
- A444
-
PCN60 Economic Evaluation of Vaccination Against Cervical Cancer in the Moscow RegionShakhanina, I. / Namazova-baranova, L. / Krasnopolskiy, V. I. / Zarochentseva, N. V. / Kozachenko, V. P. / Demarteau, N. / Shchurov, D. et al. | 2011
- A445
-
PCN65 Cost-Effectiveness of Treating Metastatic Renal Cell Carcinoma (mRCC) Patients Whose Disease Failed on one Prior VEGF-TKI Therapy with Everolimus Compared to Treating with Best Supportive Care (BSC) Alone in CanadaCasciano, R. / Chulikavit, M. / El Ouagari, K. / Wang, X. et al. | 2011
- A446
-
PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients with Kras Wild-Type Tumours in the United KingdomSamyshkin, Y. / Hertel, N. / Griebsch, I. et al. | 2011
- A447
-
PCN75 Epidemiologic and Economic Impact of HPV (6/11/16/18) Vaccination in TurkeyBakir, M. / Levent, A. / Nagy, L. / Brandtmü / ller, A. / Singhal, P. / Pillsbury, M. / Dasbach, E. et al. | 2011
- A448
-
PCN80 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in Mexico Public Insurance (Seguro Popular)Arreola Ornelas, H. / Rosado Buzzo, A. / Garcí / a, L. / Camacho, L. M. / Lechuga, D. et al. | 2011
- A449
-
PCN86 Cost-Effectiveness of Rituximab in Follicular Lymphoma First Line Maintenance Treatment from Public Payer Perspective in PolandGadaj, A. / Kalinowska, A. / Hawrylecka, D. / Holojda, J. / Krawcewicz, A. / Spychalowicz, W. / Russel-Szymczyk, M. / Szkultecka-debek, M. et al. | 2011
- A450
-
PCN91 Pharmacoeconomic Analysis of mCRC Therapy With XELOX/FOLFOX4 Regimes With Bevacizumab or Cetuximab as the First Line Treatment in RussiaTikhomirova, A. V. / Yagudina, R. I. / Kulikov, A. U. et al. | 2011
- A452
-
PCN102 Economic Evaluation of Three Formulations of Leuprolide Acetate With Atrigel® in Androgen Deprivation Therapy for Advanced Prostate Cancer in Nine European CountriesRetsa, P. / Sidhu, M. / Odeyemi, I. / Tombal, B. / Wex, J. et al. | 2011
- A453
-
PCN107 Potential Benefits of Introducing A Companion Diagnostic in Advanced Non-Small Cell Lung CancerZaim, R. / Gaultney, J. / Redekop, W. / Uyl-de Groot, C. et al. | 2011
- A455
-
PCN117 Health Resource Utilisation (HRU) Associated with Skeletal-Related Events (SREs) in Patients with Bone Metastases (BMS): Results From a Retrospective, Multinational European StudyGunther, O. / Body, J. J. / Sleeboom, H. / Hechmati, G. / Pereira, J. / Maniadakis, N. / Terpos, E. / Acklin, Y. P. / Finek, J. / Mossman, T. et al. | 2011
- A456
-
PCN122 Disclosing Traditional & Complementary Medicines (T&CM) Use to the Health Care Providers: A Qualitative Study Among Cancer Patients at a Local Hospital in MalaysiaFarooqui, M. / Hassali, A. / Knight, A. / Akmal, A. / Tan, B. S. / Farooqui, M. A. et al. | 2011
- A457
-
PCN128 EQ-5D Utility Index in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Progression During or After First-Line Docetaxel TherapyJames, N. / Eisenberger, M. / Fizazi, K. / Heidenreich, A. / Joulain, F. / Laizet, C. et al. | 2011
- A458
-
PCN133 Measuring Patients' Expectation and Satisfaction With Integrative Cancer TherapyAn, S. M. / Kim, S. H. / Kim, K. S. / Chung, H. S. / Lee, S. K. / Cheon, S. / Lee, S. H. / Park, S. / Kim, E. H. / Eo, W. K. et al. | 2011
- A459
-
PCN138 The Impact of Advanced or Metastasic Non-Small Cell Lung Cancer (NSCLC) Symptoms on Patient Daily Living and Health Related Quality of Life: Final ResultsArtal, A. / Oramas, J. / Cobo, M. / Domine, M. / Barneto, I. / Rodrí / guez-Abreu, D. / Menendez-ureñ / a, M. / Andrade, J. et al. | 2011
- A461
-
PCN148 Estimating Quality of Life in Advanced Melanoma; A Comparison of Standard Gamble, SF-36 Mapped, and Eortc QLQ-C30 Mapped UtilitiesBatty, A. J. / Fisher, D. / Winn, B. / Wang, Q. / Tolley, K. / Rowen, D. et al. | 2011
- A462
-
PCN154 Discussing the Introduction of National Screening Programs in Greece: A Delphi StudySkroumpelos, A. / Pavi, E. / Kyriopoulos, J. et al. | 2011
- A463
-
PCN159 Diagnostics and Treatment of Patients with Non-Small-Cell Lung Cancer in Daily PracticeBlommestein, H. / Groen, H. / Smit, E. / Thunnissen, E. / Uyl-de Groot, C. et al. | 2011
- A464
-
PCN165 A First Estimate of the Incremental Impact of Males HPV Vaccination on HPV-Related Diseases in EuropeBresse, X. / Largeron, N. / Marty, R. / Roze, S. et al. | 2011
- A465
-
PCN171 Underlying Causes for Sub-Optimal Utilisation of Cancer Drugs Funds in EnglandViejo Viejo, I. / Kilby, S. et al. | 2011
- A466
-
PCN177 Assessment of Reimbursement Processes and Outcomes for Cancer Drugs in Croatia – Comparison to NICE and NCCN GuidelinesVitezic, D. / Vrdoljak, E. / Bolanca, S. et al. | 2011
- A467
-
PCN183 A Population-Based Registry for the Evaluation of New Treatment Options for Patients with Metastatic Renal Cell CarcinomaDe groot, S. / Redekop, W. / Kiemeney, L. / Uyl-de Groot, C. et al. | 2011
- A468
-
PCN188 Did Decision-Making Models from National Guidelines Change 1st Line Treatment Strategy for Patients with Metastatic Colorectal Cancer (MCRC)? The Results of Large Population Based Survey in Germany 2009Kellermann, L. / Hofheinz, R. D. / Arnold, D. et al. | 2011
- A469
-
PCN193 Using Whole Disease Modelling to Inform Economic Recommendations for the Detection, Diagnosis, Treatment and Follow-up of Colorectal CancerTappenden, P. / Brennan, A. / Chilcott, J. / Squires, H. et al. | 2011
- A471
-
PDB2 Considerably Increasing Incidence of Severe Hypoglycemia 2007-2010 Versus 1997-2000 – a German Longitudinal Population-Based StudyHolstein, A. / Patzer, O. M. / Machalke, K. / Holstein, J. D. / Dippel, F. W. / Kovacs, P. et al. | 2011
- A472
-
PDB8 A Network Meta Analysis to Compare Glycaemic Control in Patients with Type 2 Diabetes Treated with Exenatide Once Weekly or LiraglutideScott, D. / Boye, K. S. / Timlin, L. / Best, J. H. / Clark, J. et al. | 2011
- A473
-
PDB13 A Prospective Registry to Identify Patients' Characteristics Associated with Achieving Target Metabolic Control After Three Months Treatment with Insulin Glulisine in Type 1 And 2 Diabetes Mellitus Patients Previously Uncontrolled on Basal Insulin and/or Other Anti-Diabetic Treatment (API Registry)Gottesman, I. / Girard, M. / Shorey, S. et al. | 2011
- A474
-
PDB18 Australia: Management of the Diabetic Foot with Pedimed® Under Real Use ConditionsTaieb, C. / Auges, M. et al. | 2011
- A475
-
PDB24 Budget Impact Analysis of the Use of Aspart Insulin During Hospitalization of Patients with Hyperglycaemia in ItalyIannazzo, S. / Pradelli, L. / Montagnoli, R. / Militano, L. et al. | 2011
- A476
-
PDB29 Modeling the Impact of Enhanced Treatment of Type 2 Diabetes Mellitus in BulgariaBoyanov, M. / Petrova, G. / Henriksen, O. / Valov, V. et al. | 2011
- A477
-
PDB35 Estimating the Real Life Daily Usage and Daily Cost of GLP-1 Receptor Agonists in the UK SettingMcDonell, A. / Zammit, D. C. / Haslam, T. / Gregor, Z. / Wilson, B. P. et al. | 2011
- A478
-
PDB40 Economic Analysis of Diabetes Treatment Goals Defined by Polish Diabetes Association: How Much Does Cost-Effective Treatment Cost?Szmurlo, D. / Schubert, A. / Kostrzewska, K. / Rys, P. / Skrzekowska-Baran, I. et al. | 2011
- A479
-
PDB45 Cost-Effectiveness of Transferring Type 2 Diabetic Patients from Neutral Protamine Hagedorn (NPH) to Detemir in Portugal SettingsCarvalho, D. / Lindner, L. / Kozarzewski, M. et al. | 2011
- A480
-
PDB50 Reduction in Comorbidities and Cost Savings Associated with Biochemical Control in Patients with Cushing's Disease: A Literature-Based AnalysisPatel, D. / Stephens, J. M. / Wiegand, P. / Pulgar, S. et al. | 2011
- A482
-
PDB61 Assessment of Quality of Life in Children and Adolescents with Type 1 Diabetes MellitusMoreira, S. / Almeida, A. / Guerra, P. et al. | 2011
- A483
-
PDB66 Achievement of Glycemic Control and Relapse Among Patients Initiating Basal Insulin from a Geographically-Diverse Us Electronic Medical Record (EMR) DatabaseAargen, M. / Wu, N. / Boulanger, L. / Lamothe, K. et al. | 2011
- A484
-
PDB71 Cross-Sectional Analysis of Ambulatory Care Expenditure Among Patients with Type 2 Diabetes Mellitus (T2DM) According to Treatment Stage and Renal Function in France Using EGB Database (Echantillon Generaliste De Beneficiaires)Guelfucci, F. / Clay, E. / Aballea, S. / Toumi, M. / Lassalle, R. et al. | 2011
- A485
-
PDB77 Impact of Knowledge on Medication Adherence Among Type 2 Diabetes PatientsAl-Qazaz, H. K. / Syed Sulaiman, S. A. / Hassali, M. A. / Shafie, A. A. / Sundram, S. / Saleem, F. et al. | 2011
- A486
-
PDB82 Development of a Health Economic Model to Compare the Prevention, Treatment and Management Strategies of Type 2 DiabetesNagy, B. / Nagyjanosi, L. / Nagyistok, S. / Jó / zwiak-Hagymá / sy, J. / Dessewffy, Z. / Kalo, Z. / Vokó / Z. et al. | 2011
- A487
-
PRS4 Effectiveness Of a Multifactorial Intervention to Improve Adherence in Patients with Chronic Obstructive Pulmonary Disease (COPD) Icepoc StudyLeiva-Fernandez, F. / Barnestein-Fonseca, P. / Leiva- Fernandez, J. / Vidal-Españ / a, F. / Garcí / a-Ruiz, A. / Prados-Torres, D. et al. | 2011
- A488
-
PRS10 A Comparative Health Economic Evaluation of Two Treatments for Grass Pollen Induced Allergic RhinoconjunctivitisRonborg, S. M. / Svendsen, U. G. / Micheelsen, J. S. / Ytte, L. / Andreasen, J. N. / Ehlers, L. et al. | 2011
- A489
-
PRS15 Estimating the Budget Impact of Introducing Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) from the Brazilian Public Health Care System (SUS) PerspectiveSuzuki, C. / Silva, N. L. et al. | 2011
- A490
-
PRS20 Costs of COPD By Disease Severity - a Comparison Over 10 YearsJansson, S. A. / Backman, H. / Lindberg, A. / Rö / nmark, E. / Lundbä / ck, B. et al. | 2011
- A492
-
PRS30 Identifying the Patient Population Where Treatment of Severe Allergic Asthma with Omalizumab (XOLAIR®) Exhibits Optimal Cost-Effectiveness in AustraliaTilden, D. / Cottrell, S. / Tocchini, L. / Frenzel, C. / Bonney, M. A. et al. | 2011
- A493
-
PRS36 The Cost-Effectiveness of Step Down from High Dose ICS/Laba Combination Therapy in Asthma in the UK SettingPaggiaro, P. / Buseghin, G. / Nicolini, G. / Patel, S. / Iannazzo, S. / Zaniolo, O. / Papi, A. et al. | 2011
- A494
-
PRS41 Cost-Effectiveness Analysis of Immunotherapy in Patients with Grass Pollen Allergic RhinitisWesterhout, K. Y. / Verheggen, B. G. / Schreder, C. H. / Sieber, J. / Augustin, M. et al. | 2011
- A495
-
PRS46 Effectiveness and Cost-Utility Estimates of Tiotropium Treatment and Pulmonary Rehabilitation Programs in French Patients with Chronic Obstructive Pulomonary DiseaseAtsou, K. / Hejblum, G. / Chouaid, C. et al. | 2011
- A496
-
PRS51 The Development of the Early Morning Symptoms of COPD Instrument (EMSCI)Palsgrove, A. / Houghton, K. / Hareendran, A. / Schaefer, M. / Setyawan, J. / Mocarski, M. / Carson, R. / Make, B. et al. | 2011
- A497
-
PRS56 Assessing Patient Report of Function: Content Validity of the Functional Performance Inventory-Short form (FPI-SF) in Patients with Chronic Obstructive Pulmonary DiseaseLeidy, N. / McCormack, J. / Hamilton, A. / Becker, K. et al. | 2011
- A498
-
PRS62 Comparison of Generic and Disease Specific Quality of Life Measures in Chronic Obstructive Pulmonary DiseaseAgh, T. / Inotai, A. / Meszaros, A. et al. | 2011
- A499
-
PRS67 Consumption Patterns and in Vitro Resistance of S. Pneumoniae to FluoroquinolonesSimoens, S. / Verhaegen, J. / Van Bleyenbergh, P. / Peetermans, W. / Decramer, M. et al. | 2011
- A500
-
PRS72 How Much Would the Universal Uptake of Gold Recommendations for Italian COPD Patients Cost?Zaniolo, O. / Bettoncelli, G. / Bosio, G. / Mantovani, L. G. / Pistelli, R. / Vaghi, A. / Villa, M. / Iannazzo, S. / Bamfi, F. / Pitrelli, A. et al. | 2011
- A501
-
PRS77 Application of Innovative Methods to Identify and Characterize Differential Responders in Clinical Trials of COPD: The Use of Mixture ModelsStull, D. E. / Houghton, K. / Gale, R. / Wiklund, I. / Capkun-Niggli, G. / Jones, P. et al. | 2011
- A502
-
PSS5 Visual Field Evolution in Glaucoma Patients Presenting With Different Disease Stages: Results From an Observational StudyGerlier, L. / Shlaen, R. / Wolfram, C. / Lamotte, M. / Verboven, Y. et al. | 2011
- A503
-
PSS11 Ranibizumab and Bevacizumab for the Treatment of Age-related Macular Degeneration: A Systematic Review and Economic EvaluationMartinez Ferez, I. M. / Flores Moreno, S. et al. | 2011
- A504
-
PSS16 Cost of Blindness in AustriaBrennig, C. / Schö / llbauer, V. / Walter, E. et al. | 2011
- A505
-
PSS22 A Cost-Effectiveness Analysis of Off-Label Biologics to Treat Sarcoid Posterior Uveitis Versus Standard of Care: Comparing Infliximab to Methotrexate and Systemic SteroidsPadula, W. V. / Yilmaz, T. / Cordero-Coma, M. et al. | 2011
- A506
-
PSS27 We Treat Eyes, Not People: The Systematic Overestimations of Utility in Age-Related Macular Degeneration ModelsVisser, M. S. / Amarakoon, S. / Missotten, T. / Busschbach, J. et al. | 2011
- A507
-
PSS32 Impact of Dry Eye on Everyday Life (Ideel) - Symptom Bother: Estimating Cut-off Scores for Dry Eye Severity GroupsAcaster, S. / Verboven, Y. / Begley, C. / Chalmers, R. / Abetz, L. / Thompson, T. et al. | 2011
- A508
-
PSS37 the Clinical and Economic Burden of Acute Otitis Media: A Large Prospective Observational Cohort Study in EuropeLiese, J. G. / Giaquinto, C. / Silfverdal, S. A. / Carmona, A. / Larcombe, J. / Garcia-Sicilia, J. / Fuat, A. / Muñ / oz Hiraldo, E. / Arroba Basanta, M. L. et al. | 2011
- A509
-
PSS42 Evaluation of the Impact of Writing Exercises and Educational Interventions on Quality of Life in Patients With PsoriasisTabolli, S. / Pagliarello, C. / Sampogna, F. / Di Pietro, C. / Abeni, D. / Centro Studi GISED, I. et al. | 2011
- A511
-
ISPOR 14th annual European congress financial disclosure information for research presetnations| 2011
- A521
-
ISPOR 14th Annual European Congress Research Abstracts Author Index| 2011
- A535
-
EX2 Health Care Resource Use Among Patients With Bipolar Disorder From Brazil and Venezuela: Subgroup Analysis of Data From A Large Multinational Longitudinal Study (WAVE-BD Study)Vieta, E. / Baptista, T. / Bifano, M. / Kerr-Corrê / a, F. / Grohs, G. / de Oliveira, I. / Vielma, X. / Montes, C. / Beluche, S. et al. | 2011
- A536
-
QA3 Costo-Efectividad De Dabigatran Versus Warfarina En El Manejo De La Fibrilacion Auricular En ColombiaAlfonso-Cristancho, R. / Herran, S. / Caicedo, M. / Gomez, E. et al. | 2011
- A537
-
VA1 Evaluacion Rápida Del Impacto De La Introduccion De La Vacuna Contra El Rotavirus En ColombiaRico Mendoza, F. A. / Porras, A. / Alvis, N. / De La Hoz, F. / Cediel, N. / Del Rio, F. et al. | 2011
- A538
-
CN2 Cancer De Pulmon Y Tabaco, Analisis Del Costo De Atencion MedicaQuintana Carrillo, R. / Arrieta Rodrí / guez, O. / Zinser Sierra, J. / Correa Acevedo, M. / Mohar Betancurt, A. / Reynales Shigematsu, L. et al. | 2011
- A539
-
HS3 The Economic Burden of Road Traffic Injuries on Health System and Society in BelizeHeredia Pi, I. B. / Pé / rez Nú / ez, R. / Hijar Medina, M. / Jones, S. / Silveira Rodrigues, E. M. et al. | 2011
- A540
-
IN4 Morbidity and Mortality of Community Acquired Pneumonia in Adults in Six Countries in Latin AmericaRosado-Buzzo, A. / Garcia-Mollinedo, L. / Camacho-Cordero, L. / Roberts, C. S. / Mould-Quevedo, J. F. / Trejo-Martinez, A. / Luna-Casas, G. et al. | 2011
- A541
-
RM2 Aplicacion de Modelos De Regresion Con Stata Para El Estudio Del Consumo de Recursos En Unidades De Cuidados Intensivos NeonatalesReyes-Lopez, A. et al. | 2011
- A542
-
PCN3 Estimacion De La Carga De Los Tumores Neuroendocrinos En ColombiaRuiz, A. / Alfonso-Cristancho, R. / Mejia, A. / Gonzalez, D. / Maestre, K. / Herran, S. et al. | 2011
- A543
-
PCN8 Cost-Effectiveness Analysis of an Opioid in Combination with Gabapentin Versus Monotherapy for the Treatment of Neuropathic PainGalindo, L. / Guajardo, J. / Plancarte, R. / Cerezo, O. / Najera, E. / Gonzalez, I. et al. | 2011
- A544
-
PCV4 Analisis Costo Efectividad En El Largo Plazo De Los Stents Liberadores De Farmaco vs Stents Convencionales En Pacientes Con Cardiopatia Isquemica En El ImssGonzalez-Diaz, B. E. / Salinas Escudero, G. / Granados-Garcia, V. / Herná / ndez, I. C. / Abbo, M. C. et al. | 2011
- A545
-
PCV9 Costo–efectividad De Los Ácidos Grasos Omega 3 Como Coadyuvante De La Simvastatina En El Tratamiento De La HipertrigliceridemiaRendon, D. / Ordoñ / ez, J. / Orozco, J. J. et al. | 2011
- A546
-
PDB5 Use of a Discrete Event Simulation Model to Estimate Clinical and Economic Outcomes of Various Self-Monitoring of Blood Glucose Regimes Plus Conventional Pharmacologic Treatment on Type-2 Diabetic Patients in MexicoZanela, O. O. / Cabra, H. A. / Muñ / oz, D. F. et al. | 2011
- A547
-
PDB10 Economic Evaluation of Duloxetine as First-Line Treatment for Painful Diabetic peripheral Neuropathy in MexicoCarlos, F. / Ramí / rez-Gá / mez, J. / Dueñ / as-Tentori, H. / Ramos, E. et al. | 2011
- A548
-
PGI4 Health-Related Quality of Life Improvements in Patients with Active Crohn's Disease Following Treatment with Certolizumab Pegol in the Music Study (NCT00297648)Hé / buterne, X. / Lé / mann, M. / Coteur, G. / Ernault, E. / Colombel, J. F. et al. | 2011
- A549
-
PHP6 Cuadro Básico Y CatÁlogo De Medicamentos Del Sector Salud: Es Actualmente Un referente Para Las instituciones PÚblicas Y/O cumple Con Los Objetivos De Su CreaciónRivera-Peñ / a, G. / Vargas-Palacios, A. / Barraza-Llorens, M. / Gutierrez-Delgado, C. et al. | 2011
- A551
-
PHP18 Impacto De La Participacion Del Farmaceutico Como Parte Del Equipo De Salud En El Primer Nivel De atencion sobre Los CostosMino-Leon, D. / Contreras-Hernandez, I. / Anaya, P. / Reyes, A. et al. | 2011
- A552
-
PHP24 ComparaÇÃo Da qualidade De Vida Entre Pessoas Com DoenÇas Crónicas E Pessoas Da Comunidade Sem DoenÇaPais-Ribeiro, J. / Silva, I. / Pedro, L. / Meneses, R. / Cardoso, H. / Abreu, M. / Melo, V. / Martins, A. / Martins-da Silva, A. / Vilhena, E. et al. | 2011
- A553
-
PHP29 Predictors of Appropriate Use of Insecticide Treated Nets in an Urban Community: The Case of Asokwa Sub-Metropolitan Area, Kumasi, Ashanti, GhanaAgyei-Baffour, P. / Mantey, K. G. / Owusu-Dabo, E. et al. | 2011
- A554
-
PHP36 Historical and Future Drivers for HTA in Reimbursement Systems in Mexico and PolandKirpekar, S. / Shankland, B. et al. | 2011
- A555
-
PHP41 Monitoring of HPV Vaccination Effectiveness Within European UnionBielik, J. / Maruš / ková / E. / Glogowski, C. et al. | 2011
- A556
-
PHP47 AvaliaÇÃo Do Mercado De Antimicrobianos No Brasil: Passo Para ImplantaÇÃo Do Monitoramento E Controle SanitÁrio Em Estabelecimentos FarmacÊuticosMota, D. M. / Araú / jo, M. A. / Santos, A. E. / Cunha, T. R. / Silva, S. F. / Bovi, R. F. / Alaver, R. T. / Albo, G. C. / Cunha, J. A. et al. | 2011
- A558
-
PIN2 Facing Critical Health Events: Economic Impact Of AH1N1 Flu Epidemic In The Mexican Health Sector, 2009-2010Gutierrez-Delgado, C. / Gó / mez-Fraga, S. et al. | 2011
- A559
-
PIN8 Evaluacion Economica De La Extension De Profilaxis Contra CMV De 100 A 200 Dias En Receptores De Trasplante Renal Con Alto Riesgo (D+ / R−)Morales Buenrostro, L. E. et al. | 2011
- A560
-
PMH2 The COST-Effectiveness Of Paliperidone Palmitate Compared To Olanzapine Pamoate In The Treatment Of Schizophrenia In SwedenPudas, H. / Hemels, M. / Mehnert, A. / Druais, S. / Martin, M. et al. | 2011
- A561
-
PMS3 Impacto Economico De La Osteoporosis Y De Las Fracturas Por Fragilidad En El instituto Mexicano Del Seguro socialClark, P. / Carlos, F. / Chico, G. / Galindo-Suarez, R. M. et al. | 2011
- A562
-
PMS8 Cost-Effectiveness analysis of Etanercept versus Available anti-Tnf and Il-6 Blockers for Treating Rheumatoid Arthritis in GuatemalaLutz, M. / Cuesta, G. / Morales, G. et al. | 2011
- A563
-
PMS13 Economic Model of Workplace Impacts of anti-Tnf therapy for Rheumatoid Arthritis in BrazilTeich, V. / Chaves, L. / Birnbaum, H. / Pike, C. / Waryas, C. / Cifaldi, M. et al. | 2011
- A565
-
PRS4 Economic Evaluation of the Use of Palivizumab as prophylactic Treatment for the reduction of Complications associated with respiratory Syncytial Virus in Pre-Term PatientsMayen-Herrera, E. / Buesch, K. / Cortina, D. et al. | 2011
- A566
-
PRS9 Disponibilidad A Pagar Por Un Metodo Efectivo Para Dejar De Fumar: Evidencias A Partir De La Encuesta Global De Tabaquismo En Adultos MÉxico 2009Heredia, I. / Servá / n, E. / Reynales, L. M. / Bautista, S. et al. | 2011
- A567
-
PSY2 ESTIMACIÓn Del Impacto Financiero En La Salud De La POBLACIÓn Mexicana Derivado De La Obesidad Y El Sobrepeso, 2000-2017Guajardo-Barron, V. J. / Gutierrez-Delgado, M. C. et al. | 2011
- A568
-
PSY7 Cost Of Managing Bleeding-Related Episodes (BRE) For Romiplostim Versus Standard Of Care (SOC) In Patients With Chronic Immune Thrombocytopenia (ITP) In MexicoArocho, R. / Northridge, K. / Rivera Hurtado, R. / Chavez, J. G. et al. | 2011
- A569
-
PUK1 Comparison Of Direct Medical Cost Of Dialysis In A Mexican Cohort Either On Peritoneal Or HemodialysisMayen-Herrera, E. / Cortes, M. / Marx, S. E. / Sterz, R. et al. | 2011
- A571
-
ISPOR 3rd Latin America conference disclosure information for reserch presentations| 2011
- A573
-
ISPOR 3rd Latin America Conference Research Abstracts Author Index| 2011
- i
-
Table of Contents| 2011
- I
-
Instructions for Authors| 2011
-
PRM9 What Guidance is Available for Budget Impact Analysis?Kusel, J. / Costello, S. et al. | 2011
-
PRM25 Switch of Prescription Drugs to the Over-the-Counter Status (Rx-to-OTC): The Development of a Flexible and Generic European Budget Impact ModelPlich, A. / Karray, S. M. / Flostrand, S. / Toumi, M. et al. | 2011
-
PRM52 Socioeconomic Patterns Among International Immigrants in Chile: The Use of ClustersCabieses, B. / Tunstall, H. / Pickett, K. / Espinoza, M. et al. | 2011
-
PRM68 Outcome Measures Hierarchy for Attention-Deficit Hyperactivity DisorderHormaechea-Beldarrain, J. A. / Prieto, L. et al. | 2011
-
PCN17 Correlations Between Surrogate End Points and overall Survival in Advanced or Metastatic Breast CancerAbdel-kader, L. / Castillo, M. A. / Lacalle, J. R. / Flores, S. et al. | 2011
-
PCN47 Clinical and Economic Burden of Breast Cancer in Japan: A Diagnosis Procedure Combination–Based Claims Database SurveyArakawa, I. / Ohta, K. / Matsubayashi, D. / Nakamura, M. / Shiragami, M. et al. | 2011
-
PCN48 Costs of Tuberous Sclerosis Complex (TSC) Neurological and Developmental Manifestations in BrazilMussolino, F. / Saba da Silva, N. / Valentim, J. et al. | 2011
-
PCN66 A Cost and Outcomes Analysis of Bevacizumab plus Folfiri Versus Cetuximab Plus Folfiri for the Treatment of First-Line Metastatic Colorrectal Cancer Patients from the Brazilian Private Payer PerspectiveCaponero, R. / Santos, E. A. / Buschinelli, C. T. / Ferracini, M. / Ngoh, C. A. et al. | 2011
-
PCN73 Cost Effectiveness of Zoledronic Acid vs. Pamidronate or No therapy for the Treatment of Bone Metastases Secondary to Prostate CancerCarter, J. A. / Bains, M. / Chandiwana, D. / Kaura, S. / Botteman, M. F. et al. | 2011
-
PCN78 Review of the Recent Pharmaceutical Additions to the Treatment of Colorectal CancerVan rooijen, E. M. / Van Gils, C. / Bazargani, Y. T. / Coupe, V. M. / Punt, C. J. / Uyl-De Groot, C. A. et al. | 2011
-
PCN77 Cost-Effectiveness of Granulocyte Colony Stimulating Factor (G-CSF) in Primary (PP) and Secondary Prophylaxis (SP) of Febrile Neutropenia (FN) in Patients with Stages 2 and 3 Breast Cancer (BC) Undergoing Cytotoxic Chemotherapy in FrancePerrier, L. / Bachelot, T. / Leon, N. / Maurel, F. / Cohen-Nizard, S. / De Liè / ge, F. et al. | 2011
-
PCN85 Cost-Effectiveness of A Human Papillomavirus Vaccination of BoysHren, R. et al. | 2011
-
PCN98 Estimating the Potential Cost-Effectiveness of Human Papillomavirus (HPV) Vaccination in Germany Using A Dynamic Transmission ModelDamm, O. / Horn, J. / Kretzschmar, M. / Deleré / Y. / Kaufmann, A. M. / Wichmann, O. / Krä / mer, A. / Greiner, W. et al. | 2011
-
PCN106 Capecitabine Plus Oxaliplatin (CAPOX) Versus Fluorouracil/Leucovorin plus Oxaliplatin (FOLFOX) in Stage III Colon Cancer: A Cost-Minimization Analysis Based on Real World Costs in the Netherlandsvan Gils, C. W. / de Groot, S. / Redekop, W. K. / Uyl-De Groot, C. A. et al. | 2011
-
PCN113 Cost-Utility Analysis of Combination Therapy of Pegylated Liposomal Doxorubicin(PLD) and Carboplatin for Korean Women with Platinum-Sensitive Ovarian CancerLee, H. Y. / Hong, J. M. / Yang, B. M. / Lee, T. J. / Kim, B. G. / Kang, S. B. / Kim, Y. T. / Kim, Y. M. / Kim, J. W. / Yang, J. M. et al. | 2011
-
PCN119 Lack of Data for Indirect Costs Associated With Treatment of Early Breast CancerUrspruch, A. / Marlow, E. / Mccormick, A. L. / Sibbring, G. C. et al. | 2011
-
PCN155 The Challenges of Estimating Costs of Palliative Care: A Systematic Literature ReviewHendry, L. / Tumur, I. / Farquharson, R. / Kroes, M. A. et al. | 2011
-
PCN158 The Influence of Health Care Policies and Health Care System Distrust on Willingness to Undergo Genetic TestingArmstrong, K. / Putt, M. / Hughes halbert, C. / Grande, D. / Shwartz, J. S. / Liao, K. / Marcus, N. / Bristol-demeter, M. et al. | 2011
-
PCN192 BIA Results Could Stop Introduction of Cost-Effectiveness Therapy into Standard Treatment : Example from CroatiaCulig, J. / Leppé / e, M. / Vrca, V. et al. | 2011
-
PDB7 Prevalence, Demographics and Treatment Characteristics of Diabetes with Lantus, NPH and Premix Insulin in a Representative Canadian CohortPetrella, R. J. / Sauriol, L. / Villeneuve, J. et al. | 2011
-
PDB28 The Roleof Diabetes and Body Mass Index on Medical Expenses, an Analysis of the Medical Expenditure Panel Survey, 2008Mitchell, B. et al. | 2011
-
PDB36 Estimating the Average Annual Cost of Treatment with Insulin for Patients with Type 2 Diabetes MellitusBurslem, K. / Das Gupta, R. / Hussein, A. et al. | 2011
-
PDB48 SHORT-Term Cost-Effectiveness of Insulin Detemir Versus NPH Insulin in Insulin-Naïve Subjects with Type 2 Diabetes in SwedenRidderstrå / le, M. / Ericsson, x. / Jensen, M. M. et al. | 2011
-
PDB80 Validation of the Updated Charlson Comorbidity Index (CCI) for Use in Patients with Diabetes or Asthma: A Comparison StudyCheng, L. I. / Rascati, K. L. et al. | 2011
-
PRS60 The Impact of Severe Poor-Controlled Asthma On Patients' Quality of Life Control StudyGalera, J. / Lahoz, R. / Herrá / ez, L. / Casafont, J. / Vennera, M. / Picado, C. et al. | 2011
-
PSS29 Treatment Patterns of Psoriasis Patients and Trends Over TimeZhang, F. / Guerin, A. / Gauthier, G. / Day, R. / Khan, Z. et al. | 2011
-
TP1 Prevalence of Lipid Abnormalities Before and After Introduction of Lipid Modifying Therapy Among Mexican PatientsAguilar-Salinas, C. A. / Rivera, M. D. / Perez, J. / Limon, F. / Diggle, A. / Ambegaonkar, B. M. et al. | 2011
-
PR1 Responsiveness of the Copd Assessment Test (CAT) Questionnaire During Exacerbations of COPDAgusti, A. / Soler, J. J. / Molina, J. / Muñ / oz, M. J. / Garcia-Losa, M. / Roset, M. / Jones, P. W. / Badia, X. et al. | 2011
-
PCN7 Impacto Presupuestario Del Tratamiento En Primera LÍnea Para CÁncer Colorrectal MetastÁsico Basado En XELOX + anti-VEGF o XELOX + anti-EGFRGomez, E. / Torrecillas, L. / Cervantes, L. et al. | 2011
-
PDB8 Cost-Effectiveness Study of Oral Hypoglycemic Agents in Outpatients Diagnosed with Type-2 Diabetes Attending a Primary Care Public Clinic in Mexico CityDiaz de Leó / n-Castañ / eda, C. / Altagracia-Martí / nez, M. / Kravzov-Jinich, J. / Cá / rdenas-Elizalde, R. / Martí / nez-Nú et al. | 2011
-
PHP37 Cross-Continental Comparison of HTA Evolution in Emerging Markets: Brazil, India and PolandKirpekar, S. / Shankland, B. / Dummett, H. et al. | 2011
-
PHP40 Promoting Efficiency of Available Capacity in A Fragmented Health System: Patients with Different Health Insurance Schemes Attended by Moh, Mexico 2006-2010Gó / mez-Fraga, S. et al. | 2011
-
PIH1 Impacto Presupuestal Del Uso De Levonorgestrel-Uis Frente A Otros Tratamientos En Menorragia Idiopatica En ColombiaRomero, M. / Karpf, E. / Sanabria, M. / Alvis, N. et al. | 2011
-
PIN3 Pursuing Financial Sustainability To Fulfill The Millenium Development Goal Six In A Fragmented SYSTEM. The Experience Of The Universal Access To Antiretroviral Drugs In MÉxico 2007-2009Rivera-Peñ / a, G. / Rios-Arenas, D. / Gutierrez-Delgado, C. et al. | 2011
-
PRS3 Costos De atencion Medica De La Enfermedad Pulmonar Obstructiva Cronica atribuibles Al TabacoRamirez-Venegas, A. / Quintana Carrillo, R. / Sansores, R. / Hernandez-Zenteno, R. / Reynales Shigematsu, L. et al. | 2011
-
PSS4 Development of a Questionnaire Assessing the Burden of Ichthyosis in InfantsTaieb, C. / Dufresne, H. / Bodemer, C. et al. | 2011
-
PSY9 Evaluación Económica De Dieta Inmunoreguladora (Inmunex Plus®) En Pacientes MexicanosSoto Molina, H. et al. | 2011
-
PUK4 COSTO-Efectividad De Intervenciones Para Insuficiencia Renal CRÓnica Terminal En MÉXICOArredondo, A. / De icaza, E. et al. | 2011
-
Editorial Board| 2011
-
AD4 Health Outcomes as a Function of Intentional and Unintentional Non-Adherence Among Eleven Costly Conditions in the EUGoren, A. / Gupta, S. / Dibonaventura, M. D. et al. | 2011
-
DA3 The Power of AssumptionsVan Hout, B. A. / Stevens, J. W. et al. | 2011
-
MO3 A Methodological Framework for Developing Models of Whole Disease Areas to Inform Resource Allocation DecisionsTappenden, P. / Brennan, A. / Chilcott, J. / Squires, H. et al. | 2011
-
MO4 Outcomes Beyond HealthJoore, M. A. / Dellaert, B. / Spijkers, L. / Severens, J. L. / Krabbe, P. / Dirksen, C. et al. | 2011
-
PMD16 The Economic and Efficiency Gains associated with the Use of A Standardised, Automated BCR-ABL Monitoring Test (SBAT): Results from A Budget Impact analysis for the USARatcliffe, A. E. / Ratcliffe, M. / O' / Hanlon, H. / Hegarty, L. / Ossa, D. et al. | 2011
-
PHP30 Biosimilars in the European MarketLindner, L. / Gimenez, E. / Rovira, J. / Espin, J. / Olry, A. / Leticia, G. et al. | 2011
-
PMD33 Economic Evaluation of Two Wound Dressings for Children with Partial-Thickness Scalds from the Public Payer PerspectiveTolentino, A. C. / Takemoto, M. L. / Fernandes, R. A. / Cukier, F. N. / Takemoto, M. M. / Cruz, R. B. / Ribeiro, A. C. / Fernandes, R. R. / Santos, P. M. / Moretti, A. I. et al. | 2011
-
PHP62 Establish Drugs Optimal Purchase ModelChang, Y. T. / Chang, T. H. / Chien, H. Y. / Tai, S. W. / Chuang, C. H. et al. | 2011
-
PSU7 Implications of Alloarthroplastic Infections in Hip and Knee SurgeryLetsch, R. / Juelicher, P. / Letsch, J. / Graf, J. et al. | 2011
-
PMD86 A Systematic Review of Economic Evaluations Conducted for Assessment of Genetic Testing TechnologiesAssasi, N. / Schwartz, L. / Tarride, J. E. / Goeree, R. / Xie, F. et al. | 2011
-
PSU11 Medico-Economic Analysis of the Impact of Malnutrition on the Post-Operative Course of Colorectal Cancer PatientsPreaud, E. / Melchior, J. C. / Carles, J. / Brami, M. / Duru, G. / Fontaine, E. / Hé / buterne, X. / Lukacs, B. / Zazzo, J. F. et al. | 2011
-
PSU13 Healthcare Resources Utilization and Associated Costs with Surgical Treatment of Dupuytrenxs Disease in Spainde Salas-Cansado, M. / Ramí / rez, E. / Pé / rez-de la Campa, C. / Ruiz-Antorá / n, M. B. / Muñ / oz, R. / Barroso, V. et al. | 2011
-
PIN12 Epidemiology, Outcomes, and Costs of Hospitalization Due to Pneumonia, Meningitis, and Septicemia in Canada from 2004 to 2010Qizilbash, N. / Mcneil, S. / Ye, J. / Gray, S. / Zanotti, G. / Todd, M. / Dartois, N. et al. | 2011
-
PIN17 Modelling Budget Impact (BI) of Vaccinating At-Risk Adults and the Elderly with 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to 13-Valent Pneumococcal Conjugate Vaccine (PCV13) in GermanyJiang, Y. / Gauthier, A. / Annemans, L. / van der Linden, M. / Nicolas-Spony, L. / Bresse, X. et al. | 2011
-
PIN21 Clinico-Economic Evaluation of Treatment of Community-Acquired Pneumonia (CAP) Complicated by Sepsis with Moxifloxacin Compared to Ceftriaxone + AzithromycinZaitsev, A. / Tyrsin, O. / Morozov, A. et al. | 2011
-
PIN43 The Total Cost of HIV Patients Treated with ARV Therapy: Real World Evidence from Three Italian Administrative DatabasesDegli Esposti, L. / Sangiorgi, D. / Soro, M. / Buda, S. et al. | 2011
-
PIN62 A Multidisciplinary Support program in Hepatitis C Treatment: An Economic EvaluationMartí / n-Escudero, V. / Garcia-Retortillo, M. / Cirera, I. / Gimé / nez, M. / Má / rquez, C. / Cañ / ete, N. et al. | 2011
-
PIN66 Cost of Virologic Failure with Etravirine and Raltegravir in the Brazilian National AIDS ProgramMorais, A. D. / Pereira, M. L. / Azevedo, H. et al. | 2011
-
PIN77 Cost Effectiveness of De-Escalation from Micafungin in the Treatment of Patients with Systemic Candida Infections Compared to Traditional Escalation from FluconazoleMasterton, R. / Casamayor, M. / Musingarimi, P. / Van Engen, A. / Odufowora-Sita, O. et al. | 2011
-
PIN95 The Impact of Influenza on In- and Outpatients' Health related Quality of Life During the Pandemic Season 2009-2010 in SpainGarin, O. / Hollmann, M. / Galante, M. / Ferrer, M. / Garcia-Alté / s, A. / Sicuri, E. / Nebot, M. / Dominguez, x. / Alonso, J. et al. | 2011
-
PIN104 Pro's in Evaluating Resource Utilisation and Absenteeism in People Receiving Influenza VaccinationWade, A. / Crawford, G. / Pumford, N. / Mcconnachie, A. et al. | 2011
-
PMH1 Adjunctive Pharmacotherapy Among Initiators of SSRI Treatment for Major Depressive Disorder: A Cohort Study Using a UK Primary Care DatabaseBall, S. / Classi, P. / Dave, S. / Maguire, A. / Kim le, T. et al. | 2011
-
PMH16 Budgetary Impact Analysis of Buprenorphine/Naloxone (Suboxone®) in Opioid Maintenance Treatment in SpainMartinez-Raga, J. / Casado, M. A. / Gonzá / lez Saiz, F. / Oñ / ate, J. et al. | 2011
-
PMH47 Validity of the Q10 Questionnaire for Diagnosis of Wearing-off Phenomena in Parkinson's Disease: A Q10 StudyRuyra, J. / Lahoz, R. / Martí / nez-Martí / n, P. / Ricart, J. / Herná / ndez, B. et al. | 2011
-
PMH62 An Examination of the Association Between Antidepressant-Related Weight Gain and Various Aspects of Worker ProductivitySchneider, G. / Roy, A. / Dabbous, O. H. et al. | 2011
-
PMH65 The Challenge of Adherence and Individualized Treatment in Severe Mental Disorders – A Nordic PerspectiveGranströ / m, O. / Dencker Vansvik, E. et al. | 2011
-
PMH71 The Impact of Once-Daily Extended-Release Quetiapine Fumarate (Quetiapine XR) on Length and Costs of Hospitalisation of Patients with Schizophrenia or Bipolar DisorderLocklear, J. C. / Wahlqvist, P. / Gustafsson, U. / Udd, M. / Fajutrao, L. / Eriksson, H. et al. | 2011
-
PMS3 Differentiation of Osteoporosis Treatments Action on Bone Remodeling: Principal Components Analysis of Bone Histomorphometry ParametersWan, X. / Zhao, Y. / Liu, E. / Burge, R. T. et al. | 2011
-
PMS5 The Effect of one-Time Physical Therapy on Biochemical Markers of Bone MetabolismGombos, G. / Fekete, J. / Domjá / n, P. / Schmidt, B. / Molics, B. / Boncz, I. et al. | 2011
-
PMS7 The Osteoporotic Fracture Incidence in Elderly Women of TaiwanChang, W. L. / Tang, C. H. / Huang, K. C. / Ling, Y. L. et al. | 2011
-
PMS53 Work Productivity and Productivity Costs of Patients with Ankylosing Spondylitis in the Czech RepublicKruntoradova, K. / Klimes, J. / Dolezal, T. / Vocelka, M. / Petrikova, A. et al. | 2011
-
PND11 Budget Impact Analysis of First-Line Treatment for Relapsing – Remitting Multiple Sclerosis in SpainSá / nchez-de la Rosa, R. / Sabater, E. / Casado, M. A. et al. | 2011
-
PND49 Initial Psychometric Properties of the Eurodolmed Questionnaire: A New Instrument to Measure Neuropathic Pain in Patients with Spinal Cord Injury (SCI) Based on Pain Intensity, Pain Interference and Pain DescriptorsTaylor, J. S. / Ruiz, M. / Soler, M. D. / Bouhassira, D. / Poole, H. / Jauregui, M. L. / Eurodolmed, S. G. / Finnerup, N. B. et al. | 2011
-
PND62 What Are The Key Drivers for Changing HTA Decisions? Example of Alzheimer'S Disease Treatment in Germany, France and UKAckermann, J. / Toumi, M. et al. | 2011
-
PUK11 Preliminary Cost-Minimization Analysis of Continuous Versus Intermittent Renal Replacement Therapy in Intensive Care Patients Experiencing Acute Renal FailureBanz, K. / Harenski, K. / Brunner, M. / von Czettritz, T. et al. | 2011
-
PHP7 Orphan Drugs for Rare Diseases in the European Union: Bridging the Gap between Drug Development and Unmet Medical Needs?Catalá / pez, F. / Peiró / S. / Gè / nova-Maleras, R. / Garcia-Alté / s, A. / Sanfé / lix-Gimeno, G. et al. | 2011
-
PHP17 Characteristics of High Cost Ambulatory Drugs in French Health Care SystemGridchyna, I. / Aulois-Griot, M. / Pulon, C. / Maurain, C. / Bé / gaud, B. et al. | 2011
-
PHP39 Toward a Better Drug Pricing Policy in Korea: Links Between Price Regulation and R&D ActivitiesJo, C. et al. | 2011
-
PHP41 Improving Use of Medicines in the Community Through InterventionsMandal, S. C. / Mandal, M. et al. | 2011
-
PHP46 Market Uptake of Orphan Drugs – A European AnalysisPicavet, E. / Cassiman, D. / Simoens, S. et al. | 2011
-
PHP49 The Pharmacist'S Perception of the Splitting Extended Release and Enteric-Coated Formulation DrugsJang, H. M. / Lee, E. K. et al. | 2011
-
PHP68 Assessment of the NHS Hospitals' Productivity in the Regional Health Authority of Thessaly in GreeceAndroutsou, L. / Geitona, M. / Yfantopoulos, J. et al. | 2011
-
PHP67 Tendering for Outpatient Prescription Pharmaceuticals: What Can Be Learned from Current Practices in Europe?Dylst, P. / Vulto, A. / Simoens, S. et al. | 2011
-
PHP79 What Are the Research Priorities in the Spanish National Health System? A Comparison of Economic Evaluations of Health Care Interventions and Public-Funded ResearchCatalá / pez, F. / Garcia-Alté / s, A. / Gè / nova-Maleras, R. / lvarez-Martí / n, E. / Morant-Ginestar, C. / Peiró et al. | 2011
-
PHP83 The Economic Burden of Disease Related Malnutrition in EuropeKalo, Z. / Inotai, A. / Nuijten, M. et al. | 2011
-
PHP87 Patient-Centered Health Care Delivery Systems: A Discrete Choice ExperimentMü / hlbacher, A. C. / Bethge, S. / Schulman, K. et al. | 2011
-
PHP126 Overview of HTA Process and Implementation Among Health Stakeholders in Bosnia and Herzegovina – Survey Based ResearchCatic, T. / Begovic, B. et al. | 2011
-
PHP141 In Search of Reform for the Greek Health Care System: Depicting the Key Opinion Leaders' ViewsTsiantou, V. / Athanasakis, K. / Pavi, E. / Kyriopoulos, J. et al. | 2011
-
PCV35 Safety and Tolerability of Bisoprolol Compared to Atenolol in Patients with Mild to Moderate HypertensionGoyal, R. / Rai, M. K. et al. | 2011
-
PCV52 Temporal Trends in the Hospital Burden of Atrial Fibrillation and Stroke on Secondary Care Costs in England Between 2006 and 2009Bakhai, A. / Righetti, C. / Punekar, Y. / Majeed, A. et al. | 2011
-
PCV57 Epidemiological Structure, Socioeconomic Effects and Burden of Disease in Patients with Oral Anticoagulation and Atrial Fibrillation in AustriaSchö / llbauer, V. / Walter, E. / Brennig, C. et al. | 2011
-
PCV61 are Hospital Costs for Stroke Underestimated in Spain?Alvarez sabin, J. / Masjuan, J. / Yebenes, M. / Mar, J. / Oliva, J. / Gonzalez Rojas, N. / Becerra, V. / Casado, M. A. et al. | 2011
-
PCV63 Direct Health Care Costs of Oral Anticoagulant Treatment in Patients with Non Valvular Atrial FibrillationAskari, E. / Hidalgo, A. / Villoro, R. / Vidal, R. / Miranda, C. / Ene, G. S. / Ivanova, A. / Gonzá / lez, A. / Llamas, P. et al. | 2011
-
PCV100 Resource Use in Patients with Acute Coronary Syndrome - an Observational Study Across Secondary and Primary Care in a UK PopulationBoggon, R. / Fox, K. A. / Begg, A. / Ray, K. / Timmis, A. / Hemingway, H. / Emmas, C. E. / Van staa, T. et al. | 2011
-
PCV98 Estimating Willingness to Pay for Hypertension Outpatient Benefit PackagesValera, M. T. / de Rosas-Valera, M. et al. | 2011
-
PCV118 Observational Study on the Treatment, Cost and Quality of Life of Subjects with Hereditary AngioedemaBouillet, L. / Montauban, V. / Finck, K. / Jeanbat, V. / Bouee, S. et al. | 2011
-
PCV117 Clinical and Patient-Reported Outcomes of Triple Combination of Olmesartan Medoxomil (OM), Amlodipine Besylate (AML) and Hydrochlorothiazide (HCT) in Hypertensive PatientsEhlken, B. / Claus, V. / Shlaen, R. / Oberdiek, A. M. et al. | 2011
-
PCV144 Stroke Prevention in Patients with Atrial Fibrillation: Inappropriate Anticoagulation and Poor INR ControlEvers, T. / O'Neil, W. M. / Ogilvie, I. M. / Welner, S. A. / Lip, G. Y. et al. | 2011
-
PCV145 Predicting Healthcare Expenditures and Utilization in Patients with Dyslipidemia Using the updated Charlson Comorbidity Index (CCI) and Prior ExpendituresCheng, L. I. / Rascati, K. L. et al. | 2011
-
PCV146 How Have Quality Checklists Improved the Quality of Published Economic Evaluations? An Example of Venous Thromboembolism (VTE) prophylaxisYoshida, E. / Plich, A. / Toumi, M. et al. | 2011
-
PCV147 Framingham Risk Score in Health Economic Modelling: A European PerspectiveCarlqvist, P. / Hermansson, J. / Moorcroft, E. / Hettle, R. et al. | 2011
-
PGI8 Cost Analysis and Incidence of Adverse Gastrointestinal Events Following Bisphosphonate Treatment Among Women with Osteoporosis in TaiwanLing, Y. L. / Tang, C. H. / Huang, K. C. et al. | 2011
-
PGI22 The Extra Health Care Costs Associated Withantimicrobial Prophylaxis in Colorectal Surgical Patients: An Exploration of Profiling Data from a University Hospital in JapanHirose, M. / Egami, K. / Tsuda, Y. / Oh, E. H. et al. | 2011
-
PGI24 Burden of Gastroesophageal Reflux Disease Among Patients With Persistent Symptoms Despite Proton Pump Inhibitor Therapy: An Observational Study in FranceBruley des Varannes, S. / Granstedt, H. / Karlsson, M. / Wahlqvist, P. / Ruth, M. / Furstnau, M. L. / Despié / gel, N. / Stå / lhammar, N. O. et al. | 2011
-
PGI26 Evaluating the Impact of Gastrointestinal Episodes on the Health-related Quality of Life of Solid Organ Transplant Recipients: Validation of the SIGIT-QoL® Questionnaire – the Mypaciente 1 & 2 StudiesBalañ / a, M. / Lahoz, R. / Ortega, F. / Puig, J. M. / Paul-Ramos, F. J. / Guinea, G. et al. | 2011
-
PIH19 Public Health Costs Associated with Outbreaks of Meningoccocal Disease: A Systematic ReviewAnonychuk, A. / Vyse, A. / Woo, G. / Tricco, A. C. et al. | 2011
-
PIH22 Cost Effectiveness of an infant Pneumococcal Conjugate Vaccine program in ChinaLiu, G. / Zhu, L. / Shen, D. / Xu, F. / Wen, L. / Roberts, C. / Dong, P. / Yue, N. et al. | 2011
-
PIH30 Endometriosis-Associated Pelvic Pain Treated with Dienogest or GNRH Analogues: Cost-Utility Comparison with 5 Years Time HorizonLukac, M. / Knight, C. / Bielik, J. / Tomek, D. / Petri, J. C. / Bojnicky, M. / Kovac, A. et al. | 2011
-
PIH56 Performance Assessment of Ga District Mutual Health Insurance Scheme in the Greater Accra Region in GhanaNsiah-Boateng, E. et al. | 2011
-
PIH68 Studying Heterogeneity in Treatment Response in Women with Idiopathic Menorrhagia Treated with Levonorgestrel-Releasing Intrauterine System (LNG-IUS): Application of Innovative Methods to Identify Differential ResponseStull, D. E. / Houghton, K. / Filonenko, A. / Wittrup-jensen, K. et al. | 2011
-
PSY17 Retrospective Chart Review Study of the Cost of Care of Systemtic Lupus Erythematousus (Sle) in Five European CountriesDoria, A. / Amoura, Z. / Richter, J. / Cervera, R. / Khamashta, M. / Guillemin, F. / Garofanno, A. / Maurel, F. / Roset, M. / Perna, A. et al. | 2011
-
PSY45 Impact of Lupus on Career Choices and Work productivity in Five European Countries: Results from the Lupus European Online (Leo) SurveySchneider, M. / Gordon, C. / Lerstrø / m, K. / Govoni, M. / Nikaï / E. / Isenberg, D. et al. | 2011
-
PSY48 Health-related Quality of Life in Russian Patients With Inhibitor HemophiliaVorobyev, P. A. / Krasnova, L. / Borisenko, O. / Zhulyov, Y. / Bezmelnitsyna, L. et al. | 2011
-
PRM7 Using Probabalistic Sensitivity Analysis in Budget Impact Models to Reduce Uncertainty and Improve Decision-MakingLatif, F. / Roberts, G. et al. | 2011
-
PRM32 Feasibility and Validity of the TiC-PBouwmans, C. / De Jong, K. / Timman, R. / Hakkaart-Van Roijen, L. et al. | 2011
-
PRM61 Sample Size Estimation for Prospective Observational StudiesCox, T. A. / Gemmen, E. / Nixon, M. / Doyle, J. / Burgess, A. J. / Jo, H. / Kamble, S. et al. | 2011
-
PCN1 Burden of Hospitalization in Patients with Advanced Lung Cancer in France and GermanyLobosco, S. / Taylor-Stokes, G. / Iyer, S. et al. | 2011
-
PCN83 Cost-Effectiveness Analysis of Combination Therapies Including Class II Anticancer Drug for Advanced or Metastatic Gastric CancerOh, J. Y. / Lee, E. K. et al. | 2011
-
PCN118 Consumption of Antineoplastic Agents in Slovak Republic Within Period of 2006-2010Gatialova, K. / Bellova, K. / Binder, R. / Foltan, V. / Snopkova, M. et al. | 2011
-
PCN121 Challenges in Conducting Pharmacoeconomic Analyses in Central and Eastern Europe – Case Study on Breast CancerSkoupá / J. / Orlewska, E. / Kalo, Z. / Há / jek, P. et al. | 2011
-
PCN149 Health State Utility Values in Breast Cancer: A Review and Meta-AnalysisPeasgood, T. / Ward, S. E. / Brazier, J. et al. | 2011
-
PCN167 National Formulary Review of the Drugs Used in Pancreatic Neuroendocrine Tumors in KoreaLee, Y. S. / Park, E. J. et al. | 2011
-
PCN181 The Health Related Quality of Life Data (HRQoL) for Health Technology Assessment (HTA) Process in Europe: Their Utilization and Impact on Opinions across HTA AgenciesStamenkovic, S. et al. | 2011
-
PCN182 What Kind of Changes Did the Publication of Two Large-Scale RCTs Lead to in Prostate Cancer Screening Guidelines?Hamashima, C. et al. | 2011
-
PCN199 An Evaluation of Statistical Methods Used to Analyse Patient-Reported Outcomes (PRO) Data in Published Metastatic Cancer StudiesGilet, H. / Bré / dart, A. / Regnault, A. / Bhandary, D. / Parasuraman, B. et al. | 2011
-
PDB21 Natural History of Beta Cell Rate of Decline and Its Effect on Development of Secondary Complications in Type 1 DiabetesRodriguez, R. D. / Sarsour, K. / Mitchell, B. / Bowman, L. et al. | 2011
-
PDB46 Cost-Effectiveness of Angiotensin Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in the Netherlands - A Markov ModelAdarkwah, C. C. / Evers, S. / Akkerman, M. / Gandjour, A. et al. | 2011
-
PDB62 The Impact of Clinical Inertia in the Treatment of Type 2 DiabetesMcEwan, P. / Prettyjohns, M. / Ketsetzis, G. / Evans, L. M. / Bergenheim, K. et al. | 2011
-
PDB67 Treatment Patterns and Health Outcomes Among Type 2 Diabetes with Comorbid Obesity in France, Germany, And UKDiBonaventura, M. D. / Isherwood, G. / Le Pautremat, V. / Eschwè / ge, E. et al. | 2011
-
PRS29 Evaluation of Stable COPD Medication Costs in Ukraine Based on GPS' Prescriptions Habits Survey ResultsHolovatyuk, I. / Zalis' / ka, O. / Tolubaiev, V. et al. | 2011
-
PRS33 A Cost-Effectiveness Analysis of Varenicline Versus Buproprion and Nicotine Replacement Therapy in GreeceAthanasakis, K. / Igoumenidis, M. / Karampli, E. / Vitsou, E. / Kyriopoulos, J. et al. | 2011
-
PRS50 The Dutch 1-Year Resource Use Results from the Experience Study, an International Registry of Real-World Outcomes for Asthma Patients Treated with Omalizumabvan Nooten, F. / Thompson, C. / Brown, R. / Groot, M. et al. | 2011
-
PRS69 Socioeconomic Determinants of Smoking Status in GreeceAthanasakis, K. / Zavras, D. / Pavi, E. / Kyriopoulos, J. et al. | 2011
-
PSS3 Incidence and Characteristics of Patients with Macular Edema Secondary to Retinal Vein Occlusion in A Representative Canadian CohortPetrella, R. J. / Blouin, J. / Davies, B. / Barbeau, M. et al. | 2011
-
PSS21 Treatment Patterns, Costs and Quality of Life in Patients With Plaque Psoriasis in DenmarkRagnarson tennvall, G. / Hjortsberg, C. / Gniadecki, R. / Jemec, G. B. / Kragballe, K. / Miller, I. M. et al. | 2011
-
PSS23 Pharmacoeconomic Analyses of Partially Hydrolyzed Infant Formulas in Prevention of Atopic Dermatitis: Comparative Results From 5 European CountriesIskedjian, M. / Berbari, J. / Navarro, V. / Farah, B. / Detzel, P. / Spieldenner, J. et al. | 2011
-
PSS39 Assessment of the Health Status Using the 12-Item Medical Outcomes Study Short Form (SF-12) Questionnaire (2578 Dermatological Out-Patients)Tabolli, S. / Pagliarello, C. / Paradisi, A. / Spagnoli, A. / Sampogna, F. / Abeni, D. et al. | 2011
-
EX4 Efectividad De Los indicadores De Calidad De La Prescripción Regionales En El Sns EspañolGarrido, E. / Sabater, F. J. / Hurtado, P. / Espinó / s, B. / Guarga, L. / Garcí / a Losa, M. / Vieta, A. / Badia, X. et al. | 2011
-
QA4 Cost-Utility of Sacral Neuromodulation Versus Augmentation Cystoplasty for Treatment of Refractory Urge Incontinence in MéxicoOliva-Oropeza, P. / Quiroz Angulo, M. E. / Marco Antonio, A. C. et al. | 2011
-
HS1 Interchangeability Between Pneumococcal Conjugate Vaccines and SchemesCiapponi, A. / Garcí / a Martí / S. / Rey-Ares, L. / Glujovsky, D. / Bardach, A. / Valanzasca, P. / Lee, A. / Cafferata, M. L. et al. | 2011
-
PCN5 Efectividad CLÍnica Y Costo-Efectividad Del Tratamiento De Segunda LÍnea Para Carcinoma MetastÁsico De CÉlulas RenalesRomero, M. / Dí / az, E. / Malagon, J. et al. | 2011
-
PCV6 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison With Enoxaparin Under the Brazilian Private Health Care System PerspectiveSchiola, A. / Silva, A. P. / Santoni, N. B. / Paladini, L. / Teich, V. / Pepe, C. / Rocha, M. M. et al. | 2011
-
PDB3 Prevalence of Severe Osteoporosis in Daily Consultation of Rheumatology and Endocrinology Services, Costs and Quality of Life of Fragility Fractures in MexicoCarlos, F. / Clark, P. / Chico, G. / Ramí / rez, E. / Franco, F. / Jasqui-Romano, S. et al. | 2011
-
PGI2 Cost-Effectiveness Analysis of the Use of Adalimumab for the Treatment of Crohn's Disease (CD) in MexicoMayen-Herrera, E. / Pozos, J. C. / Yang, M. / Cortina, D. et al. | 2011
-
PHP28 Decentralisation of Health Services Planning and Management: The Varying Perspectives of Health Workers and Community Members at Nanumba North District, GhanaAgyei-Baffour, P. / Atta, K. / Nakua, E. / Owusu-Dabo, E. et al. | 2011
-
PHP32 Lineamientos De Una PolÍtica De investigación En Salud En Chile: Acuerdos De La Comisión Técnica De investigación Sanitaria Para El Plan Nacional De Salud 2011-2020Espinoza, M. A. / Cabieses, B. / Zitko, P. / Castillo, C. / Castillo, M. / Jeria, M. M. / Valenzuela, M. T. / Delgado, M. / Ramirez, J. et al. | 2011
-
PHP35 Perceptions, Knowledge and Gaps about HTA and Health Economics by the Braziian Market Stakeholders: Ispor Brazil Qualitative ResearchAraú / jo, G. T. / Fonseca, M. / Stefani, S. D. et al. | 2011
-
PHP49 Developing Risk Sharing Arrangements – Potential for Brazil and ImplicationsShirk, R. C. / Godman, B. et al. | 2011
-
PIN1 The Epidemiologic Burden Of Hepatitis C Virus Infection In Latin AmericaSzabo, S. M. / Donato, B. M. / Yuan, Y. / Bibby, M. / Jimenez-Mendez, R. / Levy, A. R. et al. | 2011
-
PIN7 COST-Effectiveness Analysis Of Anti-Pneumococcal Vaccines Versus No Vaccination In El SalvadorDueñ / as, M. D. / Lutz, M. / Morales, G. / Strutton, D. R. / Roberts, C. / Cuesta, G. / Farkouh, R. A. et al. | 2011
-
PMH4 Economic Assessment Of Major Depressive Disorder Treatment Under Different Therapeutic Classes At IsssteRamí / rez-Gá / mez, J. / Dueñ / as-Tentori, H. et al. | 2011
-
PMS6 Health Care resource Utilization of Thai Hip Fracture Patients in Public Hospital: Cost of Illness analysis at Chiangrai HospitalSrisawi, K. / Thepnamwong, J. / Sukwong, D. P. / Reungjarearnrung, K. et al. | 2011
-
PRS7 Estudio De Costo-Efectividad De Beclometasona vs Ciclesonida Como Medicamentos Controladores En El Manejo Del asma En Pacientes Que asisten A Consulta Externa De NeumologÍa Pediátrica En El Hospital Universitario Clínica San Rafael De BogotÁ Colombia, Julio A Diciembre 2010Hinestrosa, F. / Pedraza, A. M. et al. | 2011
-
PSS2 Encouraging The Efficiency Of The National Transplant PROGRAM: Estimating The Cost Of Corneal Transplant To Be Financed By Public Institutions In The Health Sector In MEXICOCamacho, A. / Gutierrez, C. et al. | 2011
-
NI2 The Impact of Nice Guidance on the Diffusion of Medical DevicesCabo, R. / Sorenson, C. / Lynch, P. / Eggington, S. et al. | 2011
-
RS1 Literature Review On Patient Access Schemes, Flexible Pricing Schemes And Risk Sharing Agreements For MedicinesPuig-Peiró / R. / Mestre-Ferrandiz, J. / Sussex, J. / Towse, A. et al. | 2011
-
PMD1 Nd-Yag Laser Incidence Rate Comparison of Three Monofocal Intraocular Lenses (IOL) 36 Months after Cataract Surgery in FranceLafuma, A. / Coulomb, S. / Robert, J. / Berdeaux, G. et al. | 2011
-
PMD9 A1CNow® as Ambulatory Monitoring of Glycated Hemoglobin in Diabetic Type 2 (DM2) Patients: Systematic ReviewSilva, A. P. / Santoni, N. B. / Pepe, C. / Laranjeira, F. et al. | 2011
-
PMD10 Impact Analyses of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients with Multivessel Disease in France and BelgiumArvandi, M. / Bornschein, B. / Gothe, R. M. / Rioufol, G. / De bruyne, B. / De pouvourville, G. / Desmet, W. / Lefevre, T. / Fearon, W. F. / Pijls, N. H. et al. | 2011
-
PMD14 Budget Impact analysis of Two Drug-Eluting Stents for Diabetic Patients in SpainBusutil, R. / Ferko, N. / Espallardo, O. / Saadi, R. et al. | 2011
-
PMD58 Provision and Financing of Medical Aids in the Management of Rare Diseases: The Case of Amyotrophic Lateral Sclerosis (ALS)Henschke, C. et al. | 2011
-
PMD76 Are Health Technology Assessments of Medical Devices Catching up with Pharmaceuticals?Sweeney, N. / Andreykiv, M. / Wiebinga, C. et al. | 2011
-
PMD79 An Evaluation of the Non-invasive Imaging Tests Used in Current Care of Tia and Minor ischemic Stroke in the Netherlands: How Much Practice Variation is There?Buisman, L. / Silitonga, A. / Rijnsburger, A. / Redekop, W. et al. | 2011
-
PSU6 Long Term Effectiveness of Limbal Relaxing Incision (LRI) During Cataract Surgery to Correct AstigmatismGauthier, L. / Lafuma, A. / Robert, J. / Kunisk-Joinville, O. / Berdeaux, G. et al. | 2011
-
PSU25 Effectiveness of Minimally Invasive Surgery for Total Hip ArthroplastyNavarro Espigares, J. L. / Hernandez Torres, E. / Ruiz Arranz, J. L. / Padial Ortiz, M. A. / Aranda Villalobos, P. et al. | 2011
-
PIN2 Safety and Efficacy of Tenofovir as Compared to Other Nucleot(s)ide Analogues in the Treatment of Chronic Hepatitis B – A Systematic review with Mixed Treatment ComparisonWojciechowski, P. / Stozek, A. / Szmyd, J. / Gwiosda, B. / Mierzejewski, P. / Kazmierski, M. / Rys, P. / Wladysiuk, M. / Plisko, R. et al. | 2011
-
PIN9 Systematic Review of Non-Interferon Based Regimens for Chronic Hepatitis C TreatmentAggarwal, S. et al. | 2011
-
PIN29 Linezolid Versus Vancomycin for Skin and Soft Tissue Infections by Methicilin-Resistant Staphylococcus Aureus: A Cost Comparison Analysis Under the Private Payer Perspective in BrazilFujii, R. K. / Takemoto, M. L. / Mould, J. F. / Lanzara, G. / Fernandes, R. A. / Santos, P. M. / Takemoto, M. M. et al. | 2011
-
PIN28 Consumption Pattern and the Cost Analysis of Parenteral Antibiotics in AHettihewa, L. M. / Subasinghe, S. / Nilakshi, K. / Cooray, P. et al. | 2011
-
PIN30 Cost Analysis of Voriconazole Versus Itraconazole for Prophylaxis of Invasive Fungal Infection (IFI) in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Canada, France, Germany, and the United StatesGao, X. / Ji, X. / Stephens, J. M. / Schlamm, H. / Tarallo, M. et al. | 2011
-
PIN32 Economic Burden of Non-CF Bronchiectasis Enrolled in a US Managed Care PlanJoish, V. N. / Boklage, S. F. / Luong, B. / Operschall, E. / Spilsbury-Cantalupo, M. et al. | 2011
-
PIN59 A Cost-Effectiveness Analysis of Voriconazol, Anfotericine B and Caspofungin for Invasive Aspergilosis Patients in PanamaLutz, M. A. / Trujillo, J. M. / Morales, G. / Cuesta, G. et al. | 2011
-
PIN93 Assessment of Knowledge and Awareness of Hepatitis B Among General Public in PakistanHaq, N. / Shafie, A. A. / Hassali, M. A. / Ibrahim, M. I. / Saleem, F. et al. | 2011
-
PMH14 Speed of Detection of Adverse Events in Spontaneous Adverse Event Databases Compared with Epidemiological Studies: Two related CasesQizilbash, N. / Mé / ndez, I. / Sá / nchez-de la Rosa, R. et al. | 2011
-
PMH19 Cost of Relapse in Schizophrenia in Europe: The Constatre StudyHemels, M. / Diels, J. / Gonzá / lez, B. / Jensen, R. et al. | 2011
-
PMH74 Impact of Age and Gender in the Pharmaceutical Expenditure of Anxiolytics in Primary Health CareGuadalajara-Olmeda, N. / De la Poza-Plaza, E. / Barrachina-Martí / nez, I. / Vivas-Consuelo, D. et al. | 2011
-
PMH79 The Impact of Comparative Effectiveness Research on Health and Health Care SpendingBasu, A. / Jena, A. B. / Philipson, T. J. et al. | 2011
-
PMS6 A Network Meta-analysis of Biologic Treatments in TNF-IR Rheumatoid Arthritis PatientsLeReun, C. / Neophytou, I. / De Vries, R. / Diamantopoulos, A. / Pompen, M. et al. | 2011
-
PMS9 Prevalence of Shoulder Osteoarthistis and Treatment in A Large US Managed Care PopulationKozma, C. M. / Bhattacharyya, S. K. / Palazola, P. et al. | 2011
-
PMS54 The Clinical and Economic Burden of Poor Adherence with Osteoporosis Medications in IrelandHiligsmann, M. / Mcgowan, B. / Bennett, K. / Barry, M. / Reginster, J. Y. et al. | 2011
-
PND24 Cost of Symptomatic Drug Therapy in Multiple SclerosisFogarty, E. / Tilson, L. / Barry, M. et al. | 2011
-
PUK16 Known-Group Validity of the Spanish Version of the Short-Form Overactive Bladder Health Related Quality of Life Questionnaire (OABQ-SF) in Subjects with Overactive BladderArlandis-Guzmá / n, S. / Ruiz, M. A. / Errando-Smet, C. / Villacampa-Aubá / F. / Arumi, D. / Lizarraga, I. / Ruiz, L. / Rejas, J. et al. | 2011
-
PHP22 Are Hospital Medicines Prices Influenced by Discounts and Rebates?Vogler, S. / Zimmermann, N. / Leopold, C. / Habl, C. / Mazag, J. et al. | 2011
-
PHP43 Introduction of a Prescription Charge on the Community Drug Scheme in Ireland – What Impact Has It Had on Drug Utilisation?Usher, C. / Bennett, K. / Barry, M. et al. | 2011
-
PHP51 Pill Burden in South African Patients With Multiple Risk Factors for Metabolic SyndromeBurger, J. R. / Lubbe, M. S. / Serfontein, J. H. et al. | 2011
-
PHP78 Convergent Tendencies in Budget Impact Analysis Across Europe and Beyond: Germany - Don'T Lose out on the “Zeitgeist”!Bechtel, B. / Welte, R. et al. | 2011
-
PHP89 Detection of Medication Errors in the Thai FDA Database of Adverse Drug Reactions ReportsBunchuailua, W. / Bunthum, K. / Poonpanich, N. / Limpreedeechai, P. / Angkasirikumjorn, A. / Suwankesawong, W. et al. | 2011
-
PHP139 Evolving P&R Complexities are Affecting Launch Sequencing and Time to Market in 18 Developed and Emerging MarketsMarinoni, G. / Bharath, A. / Gennero, R. / Honoré / A. C. / Melck, B. / Rodrigues, T. / Uki-Eagleton, A. / Izmirlieva, M. A. / Calnan, G. et al. | 2011
-
PHP147 Opinions on Market Access Needs Differ Between Cultures and Stakeholder Sectors – Results of a Survey of ISPOR DelegatesKyral, A. / Johnson, K. I. et al. | 2011
-
PHP149 Perception of Pharmaceutical Companies on the Drug Price-Volume Negotiation in South KoreaKim, E. S. / Lee, B. J. / Lee, E. K. et al. | 2011
-
PHP161 Towards an Efficient National Drug Policy in the Russian FederationRudisill, C. / Antoun, J. / Vandoros, S. et al. | 2011
-
PHP166 On-Going Market Access Advice A Possible solution to Help Ensure Long-Term Success in Post-Marketing Clinical Studies: Cross Functional Teams or External Consultation?Kirpekar, S. / Mallinson, M. et al. | 2011
-
PHP167 Tell Me Who Your Friends are: “Peers” in Comparing Health Care SystemsCarrera, P. et al. | 2011
-
PCV1 Explorative Analysis about the Appropriateness of a GPS Longitudinal Database on Evaluating Atypical Antipsychotics in Terms of Drugs Adverse EventsHeiman, F. / Pegoraro, V. / Katz, P. / Didoni, G. / Calandriello, M. et al. | 2011
-
PCV9 Optimal Treatment Shortfalls and Worse 12-Month Outcomes for Diabetic Acute Coronary Syndrome Patients After Percutaneous Coronary Intervention in Contemporary Practice: Data from the Multinational, Prospective, Antiplatelet Treatment Outcomes Registry (APTOR)James, S. / Iniguez, A. / Pavlides, G. / Zeymer, U. / Sartral, M. / Belger, M. / Tomlin, M. E. / Norrbacka, K. / Bakhai, A. et al. | 2011
-
PCV14 Mixed Treatment Comparison of Dronedarone, Amiodarone and Sotalol for the Management of Atrial Fibrillation in AustraliaBadcock, C. A. / Lee, J. / Gonzalo, F. et al. | 2011
-
PCV30 Heart Failure (Re)Admissions in the Netherlands: Rates, Length of Stay and CostsOverbeek, J. A. / Penning-van Beest, F. J. / Herings, R. M. / Agodoa, I. et al. | 2011
-
PCV29 Recent In-Hospital Mortality Trends Among Patients with Heart Failure in the NetherlandsOverbeek, J. A. / Penning-Van Beest, F. J. / Herings, R. M. / Agodoa, I. et al. | 2011
-
PCV74 Is Treatment of Depression Cost Effective in the Management of People with CHD and Diabetes: A Systematic Review of the Economic EvidenceJeeva, F. / Davies, L. M. et al. | 2011
-
PCV85 Cost-Effectiveness of Increasing Statin Adherence for Secondary Prevention in Community PharmaciesOosterhof, P. / Van Boven, J. F. / Visser, S. T. / Hiddink, E. G. / Stuurman-bieze, A. G. / Postma, M. J. / Vegter, S. et al. | 2011
-
PCV87 Ticagrelor for the Treatment of Acute Coronary Syndromes (ACS): A Dutch Analysis Based on the Plato TrialThurston, S. / Heeg, B. / Hofsté / C. et al. | 2011
-
PCV111 Economic Burden and Health- Related Quality of Life in European Patients with Peripheral Arterial DiseaseMarrett, E. / Dibonaventura, M. D. / Zhang, Q. et al. | 2011
-
PGI6 The Development and External Validation of a Model to Predict One Year All-Cause Mortality Following Liver Function Tests in Primary Care PatientsMclernon, D. J. / Dillon, J. F. / Donnan, P. T. et al. | 2011
-
PGI11 Cost Analysis of Antihelicobacter Therapy of Gastric and Duodenum Ulcer in UkraineGerasymova, O. / Iakovlieva, L. / Tkacheva, O. et al. | 2011
-
PGI31 The Maintenance of Work-related Productivity During One Year of MMX Mesalamine Treatment for Patients with Quiescent Ulcerative ColitisYen, L. / Yarlas, A. / Hodgkins, P. / Solomon, D. / Karlstadt, R. / Kane, S. V. et al. | 2011
-
PIH26 Economic Evaluation of Dienogest for Endometriosis in the Context of Korea National Health insuranceChoi, S. E. / Lim, E. A. / Park, J. H. / Lee, M. K. / Jung, S. W. / Cho, H. Y. et al. | 2011
-
PIH38 Self Reported Health Status and Quality of Life Among Coastal Rural Population in South IndiaMuragundi, P. M. / Udupa, N. / Naik, A. N. / Tumkur, A. / Shetty, R. et al. | 2011
-
PIH64 Female Urinary Incontinence in Germany– Cost Explosion Tomorrow?Zakrzewska, K. / Henkel, I. et al. | 2011
-
PIH52 Medicine Prescribing Patterns in HIV/AIDS and Non-HIV/AIDS Children: A Comparitive Study in the Private Health Care Sector of South AfricaMocke, M. / Lubbe, M. S. / Burger, J. R. et al. | 2011
-
PIH65 What Are We Missing in Meningococcal Disease Modelling to Better Understand the Health and Economic Impact of New Vaccines?Vickers, D. M. / Anonychuk, A. / De Wals, P. / Bauch, C. T. et al. | 2011
-
PSY26 Cost Benefit Analysis of a Worksite Weight Management ProgramIdris, A. / Fernandez, I. D. / Fiscella, K. A. / Noyes, K. et al. | 2011
-
PRM2 The Reporting of Observational Studies in Spain: Analysis Using the Strobe StatementGalera, J. / Lahoz, R. / Roig, F. et al. | 2011
-
PRM8 Could Corporate Social Responsibility Predict Pharmaceutical Corporate Financial performance?Auamnoy, T. / Areepium, N. et al. | 2011
-
PCN27 Budget Impact Analysis for Chronic Mieloid Leukemia Therapy in BulgariaSavova, A. / Petrova, G. et al. | 2011
-
PCN59 Economics of Primary Prophylactic G-CSF Use in Preventing Neutropenia in Elderly Breast Cancer Patients Receiving Chemotherapy: Are Short-Term Increase in Costs Necessarily Bad?Rajan, S. S. / Lyman, G. H. et al. | 2011
-
PCN74 Cost-Effectiveness Analysis of Chemoprevention for Colorectal Cancer by Low Dose Aspirin in South KoreaLee, J. Y. / Lee, E. K. et al. | 2011
-
PCN92 The Cost-Effectiveness of Nanoparticle Albumin-Bound Paclitaxel Compared to Solvent-Based Paclitaxel in Women with Metastatic Breast CancerVandewalle, B. / Almeida, J. / Fé / lix, J. / Silva, M. J. / Luz, R. et al. | 2011
-
PCN97 Economic Evaluation of Prophylactic Pegfilgrastim and Filgrastim in Patients with Myeloablative Chemotherapy to Avoid Neutropenia in the IMSS (Mexican Institute of Social Security)Nambo-Lucio, M. et al. | 2011
-
PCN109 Cost Effectiveness of First Line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients: A Markov ModelBorget, I. / Vergnenegre, A. / Chouaid, C. et al. | 2011